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CHAPTER 1 
1.1. INTRODUCTION 
Many drugs absorbed from the gut are taken up in the blood of the 
portal system and transported to the liver. This is the usual idea about 
the absorption process of drugs taken orally. However the body has 
not only a vascular system but also a lymphatic system that may 
function in the absorption process. The question arises whether the 
latter system plays an important role in the absorption of drugs or not. 
After a meal, fat components are transported in the chyle, whereby this 
becomes white. The lymph vessels can be traced, by this white colour, 
from the gut, via the cisterna chyli and the thoracic duct, to its ending 
in the neck where it arches laterally to open near, or at, the angle of 
union of the internal jugular and subclavian veins (Yoffey and Courtice, 
1956; Miotti, 1965; Boileau Grant, 1962) (see fig. 1). In fact absorbed 
drugs could also follow this route. 
Up to now only a few drugs and nutrients are known to be absorbed 
to a large extent via the lymphvessels. For instance, a considerable 
absorption via the lymphvessels is reported for the cyclopentylether of 
ethinylestradiol = quinestrol (Giannina et al, 1967) and DDT (Rothe 
et al, 1957). Fat soluble vitamins are generally absorbed to a large 
extent via this route, e.g. vitamin A (Huang and Goodman, 1965), 
vitamin D3 (Schachteret al, 1964), vitamin E (Blomstrand and Forsgren, 
1968a), vitamin K, (Blomstrand and Forsgren, 1968b). Also the long 
chain fatty acids either in the free form or as triglycerides (Hyun et al, 
1967) and cholesterol (Chaikoff et al, 1952; Schachter et al, 1964) are 
absorbed via the lymphvessels. 
Our investigations were started to answer the following questions: 
- Which drugs are absorbed to a great extent via the lymphatics? 
- What are the properties that lead to such an absorption? 
- Is it possible to directly influence the absorption in the direction 
of the portal system or the lymphatics by means of the vehicle? 
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Fig. 1 
Route of lymph tract from intestine to the angle of union of the internal jugular and 
subclavian vein (after Miotti, 1965). 
- Are there pharmacologic consequences of influencing the route 
of absorption? 
Concerning the last question the following facts may be relevant. 
If a drug is absorbed exclusively via the portal system then it goes 
directly to the liver. The liver has a great capacity for metabolizing, 
and eventually for inactivating, a drug. If, on the other hand, a drug is 
absorbed exclusively via the lymphatic tract of the gut, then this drug 
will be transported into the blood of the vena subclavia. In this case 
the drug may reach its site of action or may be trapped in the fat 
depots whithout passing through the liver. So, a difference in intensity 
13 
and duration of action of a drug may occur if it is absorbed via one 
route rather than another. 
In this respect it is clear that the following aspects are of importance: 
A. What properties must a drug have and/or which factors are neces-
sary for it to be absorbed in a much greater concentration via the 
lymphatics than via the portal system? According to Landis (1962) 
both the blood capillaries and lymphatic vessels are freely permeable 
to all small molecular weight compounds and to all lipid-soluble com-
pounds of moderate size. For such compounds the blood capillaries 
constitute the major route of absorption as a result of rapid blood flow. 
This idea was clearly stated by Hendrix and Sweet (1917): "it is 
suggested that the practically complete absorption of protein and 
carbohydrate by the blood is not due to a selective absorption, but to 
the almost infinitely large volume of blood, as compared to the volume 
of lymph, which flows through the walls of the intestine." 
Bollman et al (1948a) found that about 80 per cent of the thoracic duct 
lymph of the rat was derived from the intestinal tract and about 20 per 
cent from the liver. The flow rates for the thoracic duct lymph, therefore, 
give a reasonable estimate of intestinal lymph flow under most con-
ditions. Portal blood flow in each case is approximately 500 to 1000 
times that of lymph. The flow rates on the basis of body weight are 
remarkably similar in the rat, dog and human (Landis, 1962). 
If such compounds as glucose and amino acids entered both types of 
vessels with equal ease, over 99 per cent would be absorbed through 
the portal vein. It implies that only if the lymph absorbs a much greater 
amount of the compound than the portal system, will the transport in 
lymph be of quantitative importance. 
B. Which are the properties of drugs and what factors are necessary 
so that the molecules, which are absorbed from the gut in the 
lymphatics, will stay there until they pass into the vena subclavia? 
Levine and coworkers (1969) investigated a number of drugs in respect 
of their absorption via blood and lymph. Soon after administration all 
the different kinds of compounds studied were found to be present 
in blood and lymph in nearly the same concentrations. These results 
suggest that molecules will interchange between the blood and the 
interstitial tissue and lymph. If molecules demonstrate an exchange 
balance between blood and lymph, then, because of the slow flow of 
the lymph, the molecules which are transported in lymph tracts to the 
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vena subclavia, will have previously passed through the liver. So the 
idea that molecules escape metabolism by the liver may only hold 
true if there is no exchange balance. 
In relation to the points in sections A. and B. the following facts are 
of importance. The lymph tract wall has the astonishing property of 
letting particles with molecular weights greater than anywhere from 
2300 to 6000 in with great ease, but not letting them out (Mayerson, 
1968). Compounds that are transported in considerable amounts by the 
lymph, like the fat soluble vitamins and DDT, have low molecular 
weights, but are transported in lymph together with fat. This fat is 
transported mainly in the form of chylomicrons. These are relatively 
large colloidal fat globules, of 200 to 300 nm diameter, which are 
produced in the intestinal mucosa. It is known that for 80 per cent or 
more the fat soluble vitamins and DDT are present in chylomicrons. 
So if small molecules with a molecular weight greater than 6000 
bind tot chylomicrons the resulting complexes are transported in the 
lymphatics and thus the small molecules stay there. These facts may 
answer the questions posed. If one wants to detect whether drugs are 
transported via the lymphatics in considerable amount, the lipophilic 
character of such drugs could be of importance. Moreover the admini-
stration in fatty preparations may be decisive. Significant absorption 
via lymph tracts of compounds that bind strongly to protein molecules 
has not, up to now, been reported. 
C. Could the pharmacologic consequences of influencing the route 
of absorption be connected with fat kinetics? DDT and the fat 
soluble vitamins arrive in the blood of the vena subclavia bound to 
chylomicrons. Chylomicrons display a characteristic behaviour. They 
disappear very fast from the blood with an apparent half-life of only 
a few minutes. It is an interesting question to what extent compounds 
bound to chylomicrons follow these events. 
Other aspects may be considered. 
Some natural steroids like testosterone and nandrolone are decom-
posed by the liver when given orally (Biskind and Mark, 1939; Biskind, 
1940; Kupperman, 1965). For that reason no pharmacologic effect is 
achieved. Alibrandi et al (1960) investigated some steroid compounds 
and concluded that all compounds tested exhibited an increase in 
specific activity when administered orally in oily solution instead of 
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aqueous suspension. The question now arises whether the increase in 
specific activity is the result of an enhanced lymphatic transport due to 
the use of oil as vehicle. 
Rothe et al (1957) looked for lymphatic absorption of DDT and its 
metabolites in the rat. About 60 per cent of the dose of DDT, which 
was not lost in the intestinal contents and faeces, was found in the 
chyle. They could not account for the remaining 40 per cent but they 
state: "Because of the diffuse, poorly defined nature of the lymphatic 
system, collaterals which bypassed the cannulated duct are a real 
possibility. It seems likely therefore that most, if not all, of the DDT 
derived materials are absorbed by way of the lymphatic system, but 
the possibility of some absorption by way of the hepatic portal system 
can not be excluded by these experiments." 
So these investigators believe in nearly a hundred per cent absorption 
of DDT via the lymphatic system. Also the transport of cholesterol 
has always been regarded as occurring exclusively via the lymphatic 
pathway (Treadwell and Vahouny, 1968). However, recent results of 
MacMahon et al (1971) indicate that under certain circumstances, a 
significant proportion of cholesterol and also vitamin E may be absor-
bed via the portal vein. 
To what extent lymph is transported by collaterals from the lymphatic 
system to the vascular system has been studied in rats by Threefoot 
et al (1963). They visualized the lymphatic vessels by the injection of 
coloured plastic. In those animals in which the cisterna chyli was not 
ligated or was ligated immediately before the injection of the plastic, 
no additional lymphatico-venous communications were observed. Only 
when the cisterna chyli was ligated 21-32 days beforehand, lymphatico-
venous communications were found. So it is likely, that there is an 
enlargement of pre-existing subsidiary channels which under normal 
circumstances carry little or no lymph. In the present investigations no 
further attention was paid to the role of collaterals in the lymphatic 
transport. 
1.2. THE STRUCTURE OF THIS THESIS 
The aim of this investigation is to gather more information about the 
questions posed. For that reason the following study was conducted. 
In chapter 2 a description of the materials, animal experiments, and 
analytical procedures used in this study is given. 
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Chapter 3 describes the influence of dosage forms (i.e. triolein, 
micellar solution and propylene glycol), partly on rats with bile can-
nulation, and on lymphatic or portal absorption of DDT. The degree 
to which fat absorption is important for the transport of DDT via the 
lymph duct was investigated; a form of administration was sought 
which would be optimal in this respect; also the influence of bile on 
this process was examined. 
Chapter 4 gives 1. The amount of various compounds (radioactively 
labeled) collected in the thoracic duct lymph at different intervals up 
to 24 hr after oral administration. The amount in a number of excretion 
and organ samples during and after 24 hr was determined. In a num­
ber of cases the effects of both fat and propylene glycol administration 
were studied. The extent of lymphatic transport dependent on the site 
of administration was also studied. 
2. Ratios of concentrations of various drugs in mesenteric lymph to 
portal blood during absorption. In the case of a number of drugs the 
total amount of radioactivity was studied as was the absorption of 
the pure drug. 
3. Determination of lipophilicity as Δ Rm values against butter yellow. 
With the aid of reversed phase chromatography these values were 
determined. 
4. The extent to which the lipophilicity of the drugs determined the 
transport in the lymph was examined. 24 hr absorptions were cor­
related with ARm values. 
In chapter 5 the results are discussed of studies concerning whether 
and to what extent binding of drugs to chylomicrons could play a 
role; to what degree binding to other lipoproteins and to other proteins 
occurs; the extent to which the drugs are bound to nucleus or skin of 
the chylomicrons under various conditions. Therefore binding studies 
were carried out with vitamin D3, DDT, dieldrin, quinestrol and 
mestranol to lymph components under various conditions. 
Chapter 6: By measuring the amount and degree of conversion of DDT 
and aldrin in fat and liver samples at various times, we attempt to get 
an impression of the differences in distribution and metabolism in 
the body as a result of altered transport via portal vein or lymph tract. 
Therefore the influence of fatty or non-fatty dosage forms on fat/liver 
concentration quotient and degree of metabolism in fat of DDT and 
aldrin was investigated. 
Chapter 7: Conclusions and summary. 
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CHAPTER 2 
EXPERIMENTAL PROCEDURES 
2.1. ANIMALS 
The animals used were rats. It is known that rats have great resistance 
to infections and post-operative shock (Lambert et al, 1965). This is, 
for many investigators including ourselves, the main reason for using 
these animals for lymph cannulations. The animals used were male 
Wistar rats, weighing 210-230 g. 
2.2. OPERATION TECHNIQUE 
2.2.1. Narcosis 
Operation was done under halothane-nitrous oxide narcosis. This was 
carried out with the "Loosco T.I.L.C. Fluothane vaporiser". This nar-
cosis is easy to handle for long operations by keeping the N20 and 
0 2 flow minimal, e.g. 1 I O2, 0.5 I N20. The mixture contains approx. 
0.8 per cent fluothane. 
2.2.2. Cannulation 
Polythene cannulae were used for all cannulations except in the case 
of bladder cannulations where polyvinyl chloride was used. The can-
nulae were supplied by Talas Company, The Netherlands. 
2.2.2.1. Lymph cannulations 
References to lymph cannulation are given by the following authors: 
Bollman et al (1948a); Gallo-Torres and Neal Miller (1969); Yoffey and 
Courtice (1970); Lambert et al (1965). In the cannulation of the thoracic 
duct and the mesenteric duct we followed the methods of Bollman et 
al (1948a). 
2.2.2.2. Stomach cannulation 
A cannula was inserted in the upper part of the stomach with a ligature 
18 
according to Lambert et al (1965). This stomach cannula was used for 
an infusion that contained 0.9 per cent NaCI and 0.04 per cent KCl 
(Sylvèn and Borgström, 1968). 
2.2.2.3. Cannulation of the urinary bladder. 
A cannula was inserted in the urinary bladder in order to avoid con-
tamination of urine with faeces. 
2.2.2.4. Bile fistula 
Under certain circumstances, as indicated elsewhere, bile fistula was 
employed according to the method of Lambert et al (1965). The cannula 
is inserted in the upper part of the bile duct, so that the pancreatic 
juice that leaves the bile duct via the lower part is not obstructed. 
With this method a bile delivery of 48 hr could be collected (Gallo-
Torres et al, 1969). The bile cannula was conducted to the outside via 
the incision in the abdomen. All other cannulae were conducted via 
the back under the skin and left the body near the tail. 
2.2.2.5. Cannulation of portal vessels. 
A cannula was inserted in one of the branches of the portal vein. It is 
obviously advantageous to cannulate one branch of the portal tract, 
since only a part of the portal vein is obstructed and clotting occurs 
only in this cannulated branch. Moreover the liver lobe is also supplied 
with blood via the arteria hepática. Before insertion the cannula was 
filled with saline containing heparin 1 : 25. The portal cannula was con-
nected with an infusion of saline containing heparin 1 : 100. The infusion 
had a flow of 0.16 ml/hr. So very dilute heparin was delivered at the 
site of insertion in order to prevent local clotting. The rats survived 
this portal branch cannulation for up to one day. 
2.3. EXPERIMENTAL DESIGN 
2.3.1. Restraining cage 
After the cannulation procedure the rats were placed in a restraining 
cage. A modified model of the cage of Bollman (1948b) was used 
(see fig. 2). Front and back are made of perspex, between these sides 
are copper bars. The four upper bars can be removed. In this manner 
a rat can be held in the cage. The inside sizes of the cage are I. 
16.0 cm, br. 4.5 cm, h. 4.5 cm. Cages of these sizes are suitable 
for a rat of about 220 g. A plastic funnel could be inserted through 
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the back of the cage and attached to a plastic container. The con-
tainer stood in ice water. The vessels carrying the other samples 
were also cooled in this way. Via a slit in the front of the cage the 
rat had free access to water. The surrounding air temperature was 
kept constant at 27 0C during the experiment. 
Fig. 2 
Outline of the experimental set-up. 
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2.3.2. 
Two kinds of experiments were carried out. 
A. In the first series of experiments cannulae were placed in the 
thoracic duct, stomach and in the urinary bladder. In certain experi­
ments bile was collected from the bile fistula (see chapter 3). 
During the whole experiment the rats were starved and saline infusion 
was given via the stomach cannula. 15-20 hr after the operation the 
infusion was interrupted by the administration of the pharmacon, 
followed by 1 ml saline. After administration lymph was sampled from 
0-2, 2-4, 4-6, 6-8, 8-12 and 12-24 hr, urine and faeces and, in certain 
experiments bile, were sampled during the whole 24 hr period. After 
that period samples of cardiac blood and perirenal fat were taken 
under ether anesthesia. The liver and the intestine with stomach 
together with the intestinal contents were removed. A diagram of the 
experimental set up is given in fig. 3 A. 
B. In the second series of experiments cannulations of the mesenteric 
duct, stomach and the portal vein were carried out. Before the 
operation the rats were starved for 15-20 hr. As described (this 
chapter 2.2.2.5.) heparin-saline infusion was given via the portal can­
nula. An infusion of saline via the stomach cannula was also con­
ducted. In these experiments the pharmaca, followed by 1 ml saline, 
were administered directly after the operation via the stomach cannula. 
Lymph and blood samples were obtained г, 1, 2, 3 and 4 hours after 
administration. The sample collection lasted from about 5 min. before 
until about 5 min after the times mentioned. The lymph which was 
collected from 3 hours 5 min until 3 hours 55 min after administration 
was used for the analytical determination of the unchanged pharmacon. 
For this determination in portal blood a sample, taken under ether 
narcosis, was used from about 4 hr after administration (see fig. 3 B). 
2.4. STIMULATION OF THE LYMPH FLOW 
Several investigators have shown that the thoracic duct lymph output 
rises when saline is given via the stomach (Yoffey and Courtice, 1970; 
Gallo-Torres and Neal Miller, 1969). Such an infusion is given since in 
the absence of infusion of saline into the stomach there is some lymph 
flow but it is minimal. If insufficient fluid intake is prolonged there is 
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usually obstruction of the catheter due to clotting of the lymph with 
subsequent loss of the preparation. 
In the present experimental set up the rate of saline infusion was 
2.5 ml/hr and an average of 1.5-2 ml/hr lymph was sampled. 
samples ai 24hre 
after adminietrabion 
sampi \ng during 
2h hrs after 
admimetration 
meaentenc 
lymphatic cannula 
stomach 
cannula 
Fig. ЗА and B. 
Fig. A shows the schematic picture of the experimental set-up with cannula construction 
and sampling system for experiment A 
Fig. В shows the same for experiment В 
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2.5. PREVENTION OF CLOTTING 
In order to prevent clotting of the lymph about 3 μΙ heparin (thrombo-
liquine, 1 ml = 5000 i.u.) was introduced in the collecting vessel. This 
was also done to prevent clotting of blood. In those cases in which we 
wanted to study the chylomicrons and lipoproteins of the lymph we 
used EDTA (1 mg/ml) instead of heparin to prevent clotting. Moreover 
physical and chemical changes in the isolated chylomicrons and 
lipoproteins can be avoided by the addition of EDTA (Ontko, 1970). 
2.6. MATERIALS 
2.6.1. Unlabelled compounds 
The following compounds were used during the investigations. DDD and 
DDE (Aldrich); aldrin and dieldrin (Analabs); n-butylphthalate, phthalic 
acid di- (2 ethyl-hexyl) ester = DOP, 3-methylcholanthrene (East­
man Kodak Co.); DDT (Fluka A. G. - Buchs S. G.); cyclandelate (Gist-
Brocades); bishydroxycoumarine ( S. A. F. Hoffmann-La Roche & Co 
Ltd.); butylated hydroxytoluene = B.H.T. (I.C.I.); chlorotrianisene (K &K 
Laboratories, inc.); cholesterol (Koch-Light Lab. Ltd.); lindane (Inter-
pharm); cortisone, digitoxin, p-dimethylaminoazobenzene, phthalic acid, 
phthalic anhydrid, vitamin A, vitamin K, (Merck A. G.); ethynylestradiol, 
lynestrenol, ß-sitosterol, vitamin E (Organon); 25-hydroxycholecalciferol 
= 25-HCC, vitamin D3 (Philips Duphar); cholesterol palmitate, diethyl-
stilbestrol, mestranol, 17-methyltestosterone, nandrolone, progeste-
rone, testosterone (Sigma Chem. Comp.); quinestrol (Warner-Lambert 
Research Institute); 17-methyltestosterone-3-cyclopentyl-enol-ether, 
quingestrone (Warner-Vister); aroclor, 2,2', 4,4', 5,5', hexachlorbiphenyl 
= H.B.F. (T.N.O. Zeist); л 1-tetrahydrocannabinol = Δ 1-THC (gift). 
With the aid of thin layer chromatography impurities or by-products of 
the compounds above could not be detected. Investigated was also 
hexadecane (Baker). Identity and purity of this compound was examined 
by means of the boiling point. As constituents for the dosage forms 
the following compounds were used: lecithin 95-100 per cent (B.D.H.); 
sodium glycochenodeoxycholate, sodium glycocholate, sodium tauro-
chenodeoxycholate (Calbiochem); glucose (N.V. Corn Products 
Сотр.); sodium chloride (Merk A. G.); protifar* (Nutricia N.V.); 
mono-olein, oleic acid and triolein (Unilever Emery). 
* Trade name for a complex mixture of proteins 
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2.6.2. Radioactive compounds 
A survey of the radioactive compounds used in the present in­
vestigations is given m table 1. All the compounds were tested with 
thin layer chromatography. The compounds were at least 98 per cent 
pure. 
Table 1 
Compound Specific activity Manufactured by 
83 цСі/тд 
50 mCl/mM 
1 1 цСі/тд 
1 11 цСі/тд 
Aldrin-14C(u) 
bishydroxycoumarin-
-nnethylene-uC 
cholesterol-4-"C 
cyclandelate-carbonyl-"C 
D D D (p-chlorophenyl-uC) 
= 1 1-dichloro-2 2-bis 
(p-chlorophenyl) ethane 
DDE (p-chlorophenyl-"C) 
= 1 1-dichloro-2 2-bis 
(p-chlorophenyl) ethylene 
DDT (p-chlorophenyl-^C) 
= 1 1-bis-(p-chlorophenyl-uC) 
-2 2 2 tnchloroethane 
dieldnn-'O 
diethylstilbestrol-
-monoethyl-1-,4C 
p-dimethylammoazobenzene-'4C 
D O P -carbonyl-MC 
= phthahc acid di-(2 ethylhexyi) eater 1 3 цСі/тд 
52 0 mCi/mM TRC Amersham 
23 9 mCi/mM 
64 2 mCi/mM 
39 mCi/mM 
1 72 mCl/mM 
hexadecane-1- , 4C 
lindane- , 4C (u) 
lynestrenol-4-,4C 
me3tranol-4-14C 
3-rnethylcholanthrene-6-'4C 
nandrolone-4-,4C 
phthalic anhydrid-carbonyl-14C 
progesterone-4-'4C 
quinestrol-6,7-3H 
Δ 1-THC-3H (G) 
= Δ 1-tetrahydrocannabinol 
vitamin D,-4- , 4C 
47 2 mCi/mM 
54 mCi/mM 
10 1 μ&/πΐ9 
145 uCi/mg 
5 47 mCl/mM 
102 3 цСі/тд 
8 1 9 mCi/mM 
57 3 mCi/mM 
572 цСі/тд 
142 цС1/тд 
55 4 цСі/тд 
Philips Duphar 
TRC Amersham 
Gist-Brocades 
synthesized from DDT- I 4 C 
see 2 6 3 
1 11 цСі/тд idem 
Fluka A G -Buchs S G 
TRC Amersham 
TRC Amersham 
N E N 
synthesized from phthalic 
anhydrid-carbonyl-'4C 
TRC Amersham 
TRC Amersham 
Organon 
Organon 
N E N 
Organon 
Mallinckrodt 
N E N 
Warner Lambert Research 
Institute 
Δ 1-THC was tritiated by 
TRC Amersham The crude 
product was purified 
see 2 6 3 
Philips Duphar 
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2 6 3 Preparation of radioactive compounds 
Certain compounds had to be synthesized or purified in our laboratory 
DDD (p-chlorophenyl-14C) 
This was synthesized from DDT-14C according to Langer (1944) To 
DDT (p-chlorophenyl-14C), 23 9 mCi/mM, was added unlabelled DDT 
resulting m 75 mg DDT with a specific activity of 1 цСі/тд Mixing with 
0 9 ml alcohol 96 per cent, 56 mg granulated zinc and 150 ml cone HCl 
followed This mixture was fluxed during 8 hr and thereafter extracted 
with chloroform The chloroform was evaporated and the remaining 
material purified on a pre-coated silica-gel glass plate of 2 mm 
thickness (Merck A G Darmstadt, Germany) Using the method of 
Abbott et al (1964) the plate was developed with n-hexane DDD was 
separated in this way from DDT and DDE After localization of DDD 
by scanning, silica-gel containing the adsorbed compound was scraped 
off the plate and eluted with n-hexane The yield was 40 per cent 
Identity and chemical purity were studied with a L К В gaschromato-
graph-Mass spectrometer, type 9000 of Bromma, Sweden, with column 
content OV-17 3 per cent, t 0 180-220 The synthetized DDD proved 
to be more than 98 per cent pure The specific activity of the DDD 
was 1 11 uCi/mg 
DDE (p-chlorophenyl-uC) 
For the synthesis of DDE the principle (Bailey et al, 1969) that DDT 
splits off HCl easily m alcoholic KOH was used DDT-14CF 23 9 mCi/mM, 
was mixed with unlabelled DDT resulting in 50 mg with a specific 
activity of 1 цСі/тд This product was mixed with 2 5 ml 10 per cent 
alcoholic KOH, and shaken during 1 hr After that an extraction with 
petroleum benzin (b ρ 40-60 0C) was carried out The petroleum 
benzin was evaporated and the remaining material purified on a 
silica-gel glass plate as described for DDD Identity and chemical purity 
were also tested in the same way DDE proved to be more than 98 
per cent pure A yield of about 70 per cent was obtained The specific 
activity of the synthesized product is 1 11 цСі/тд 
D O P-carbonyl-14C 
This compound was synthesized from phthalic anhydride-carbonyl-14C 
according to Iwakura (1945) Phthalic anhydride-carbonyl-14C, 8 19 
mCi/mM, was mixed with unlabelled phthalic anhydride resulting in 
29 6 mg, that is 0 2 mM, with specific activity 100 цСі/0 2 mM This 
25 
product was mixed with 1.5 ml dry benzene, 0.5 mM 2-ethyl-hexanol 
(65 mg = 78 μΙ) and a small drop (added with capillary) of H2S04. This 
mixture was refluxed overnight and thereafter the benzene was boiled 
off. The remaining material was dissolved in ether and purified accor­
ding to Braun (1965) on a pre-coated silica-gel glass plate of 2 mm 
thickness. The plate was developed with methylene chloride. Silica-gel 
containing the adsorbed product was scraped off the plate and eluted 
with ether. A yield of about 95 per cent was obtained. The synthesized 
compound had a specific activity of 1.3 цСі/тд. The identity and 
chemical purity were tested as described for DDD. The compound 
proved to be more than 98 per cent pure. 
Δ 1-Tetrahydrocannabinol-3H (G). 
The unlabelled product was received as a gift. Part of it was tritiated 
by TRC Amersham. The tritiated crude product was purified on a pre-
coated silica-gel glass plate G of 2 mm thickness. The plate was 
developed with benzene. After localization, silica-gel with the adsorbed 
compound was scraped off the plate and eluted with ether. Identity 
and chemical purity were tested with the L.K.B. gaschromatograph-
mass spectrometer as described for DDD-14C. The product with a 
specific activity of 142 цСі/тд proved to be pure. 
2.7. ANALYTICAL PROCEDURES 
2.7.1. Sampling procedures. 
Radioactivity in lymph-, urine- and tissue samples was determined in 
the usual way. 
2.7.1.1. Lymph. 
A. In the first series of experiments (see 2.3.2.A.) lymph was sampled 
in a volumetric flask of 25 ml, the amount was determined by weighing 
and thereafter this lymph was diluted with saline to 25 ml. Two portions 
of 4 ml of the diluted lymph were pipetted into two liquid scintillation 
counting vials and the radioactivity was determined (see 2.7.2.1.). 
B. In the second series of experiments (see 2.3.2.B.) the lymph that had 
been sampled at У
г
, 1, 2, 3 and 4 hr after administration was put into 
two counting vials, the amount (0.1 g) measured by weighing and the 
radioactivity determined. The lymph, produced 3 hr 5 min - 3 hr 55 
min after administration was sampled and the amount measured by 
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weighing. A portion (0.1 g) was put into a counting vial and the 
radioactivity determined. This was done in duplicate. In the rest of 
this lymph (1 g) the drug together with lipoids were extracted accor­
ding to the procedure of Bligh and Dyer (see 2.7.3.). In this extract 
the amount of unmetabolized product was determined by means of 
reversed phase chromatography (see 2.7.4. and 4.2.3.). Since the total 
amount of radioactivity and the amount of unchanged drug in the lymph 
sample can be estimated, the percentage unchanged drug can also 
be calculated (see 2.7.4.). 
2.7.1.2. Cardiac blood and portal blood. 
Cardiac blood in the first series of experiments (see 2.3.2.A.) was 
sampled at once into two counting vials and the amount (0.2 g) 
measured by weighing. Radioactivity was determined according to 
2.7.2.1. Portal blood, sampled (0.2 g) in the second series of experi­
ments (see 2.3.2.B.) at Уг, 1, 2, 3 and 4 hr after administration of the 
drug, was treated similarly to cardiac blood. In a certain number of 
experiments (see 2.3.2.B. and chapter 4.2.1.) at 4 hr after admini­
stration of the drug 1.4 g of portal blood was taken under ether 
anesthesia. Two parts (0.2 g) of this sample were treated similarly 
to cardiac blood. The rest (1 g) of these samples was diluted with 
aqua dest. to 4 ml and extracted. The percentage unchanged drug in 
these blood samples was determined in the same way as for the 
lymph samples mentioned under 2.7.1.1.В. 
2.7.1.3. Intestine and stomach; faeces and intestinal contents. 
A. Intestine. 
The intestine with contents was weighed. Thereafter the intestinal con­
tents were rinsed out of the intestine with 5 changes of saline, finally 
the intestine was emptied and, after drying the outside between filter 
paper, weighed. The weight of the intestinal contents was obtained by 
subtracting the above values. The intestine, made up to a weight of 
25 g with aq.dest. was homogenized in a waring blendor for 2 min. 
The radioactivity was determined in two portions of 4 g of the homo-
genate (see 2.7.2.1.). 
B. Faeces and intestinal contents. 
The diluted intestinal contents (see A.) were mixed with the weighed 
faeces and aq.dest. to a weight of 50 g. Homogenisation in a waring 
blendor for 2 min followed. The radioactivity was determined in two 
portions of 2 g of the homogenate (see 2.7.2.1.). 
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2.7.1.4. Urine. 
Urine was sampled in a volumetrie flask of 50 ml. The sample was made 
up to 50 ml with aq.dest. Two portions of 10 ml were placed in two 
counting vials and the radioactivity was determined (see 2.7.2.1.). 
2.7.1.5. Bile. 
Bile was treated similarly to the lymph of the first series of experiments 
(2.7.1.1.Α.). 
2.7.1.6. Liver. 
The liver was weighed, thereafter water was added to a weight of 30 g 
and the whole was homogenized in a waring blendor. In two portions 
of 2 g of the homogenate the radioactivity was determined as decribed 
for blood (see 2.7.1.2.). 
2.7.1.7. Perirenal fat. 
Perirenal fat was weighed and a mixture of aq.dest. - isopropyl ale. 
1 : 1 was added to a weight of 15 g and the whole was homogenized 
for 2 min in a waring blendor. In two portions of 2 g of the homo­
genate radioactivity was determined according to 2.7.2.1. 
2.7.2. ASSAY OF 14C- AND 3H-RADIOACTIVITY 
2.7.2.1. Liquid scintillation counting (LSC). 
Radioactivity in all animal samples, blood- and liver samples excepted, 
was determined by mixing with 10 ml instagel (Packard) in a liquid 
scintillation counting vial followed by counting the radioactivity. This 
was performed in a Packard Tri-Carb liquid scintillation spectrometer 
model no 3380, equiped with an Absolute Activity Analyzer, model no 
544 (Triple A). Blood samples (0.2 g) and liver homogenates (2 g) 
were treated in a different way. The sample was mixed in a counting 
vial with 1.5 ml soluene - 100 (Packard) - isopropanol 1 : 1 and the 
mixture warmed for 15 min at 40 0 C in a waterbath with shaking. Then 
0.5 ml H202 (35 per cent) was added with shaking and finally after 
30 min 15 ml of 0.5 N HCI-instagel 1 : 9 was added to it and the 
radioactivity was counted. 
Counting of 14C radioactivity. 
An AES-quench curve was made with the aid of 14C-hexadecane, 
quenched with different amounts of chloroform. The triple A was 
adjusted by means of the counting efficiencies of this quench curve. 
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Counting efficiencies were as a rule higher than 65 per cent. Below 
this percentage corrections of measured CPM to DPM were calculated 
with the aid of the internal standard method. 
Counting of 3H-radioactivity. 
An AES-quench curve was made in the same way as for 14C, but using 
3H-hexadecane. Since tritium has a much lower counting efficiency 
than 14C, corrections of measured CPM to DPM for every determination 
were made by means of this quench curve. When the counting efficien-
cy was under 15 per cent CPM corrections were made with the aid 
of the internal standard method. The yield of 14C- and 3H- radioactivity 
was checked in all tissue samples investigated by us. A known amount 
(100,000 DPM) 14C- and 3H-hexadecane was mixed with the non-active 
samples and the radioactivity determined. The yields were greater 
than 99 per cent of the added amount. 
2.7.2.2. Scanning of the thin layer chromatograms. 
When radioactive spots on thin layer chromatography (TLC) plates 
were detected with a scanner, a Berthold Dünnschicht-scanner II was 
used. This scanner was equiped with a synchronously recording 
Metrawatt A.G. writer. 
2.7.3. EXTRACTION OF LIPOPHILIC PRODUCTS 
For the extraction of fat soluble compounds the procedure of Bligh and 
Dyer was used (1959). This method is generally employed for the 
extraction of lipophilic compounds by Avioli et al (1967). The lipoid 
extractions were performed in series. 
A quantity of 4 ml or 4 g of tissue sample was homogenized and 
shaken for 10 min with a mixture of 5 ml chloroform and 10 ml 
methanol. The resulting homogeneous mixture was sucked off via a 
glass scintered filter, covered with celite 545. The celite filter was 
washed with 10 ml of chloroform and the combined filtrates shaken 
for 10 min. Thereafter 5 ml of water added and shaken again for 10 
min. After separation the lower layer contains the compound (called 
layer Α.). In order to obtain a quantitative extraction the upper layer 
was again treated with 10 ml of chloroform, added by sucking off via 
the celite filter. The chloroform layer, obtained after separation was 
mixed with chloroform layer A. The resulting solution contained the 
compounds to be measured. This fraction was concentrated under a 
flow of N2. 
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The method described was checked with 14C-cholesterol and 14C-DDT. 
A recovery of at least 99 per cent was achieved. If separation did not 
occur the sample was centrifuged for 5 min at 3000 r.p.m. 
2.7.4. THIN LAYER CHROMATOGRAPHY 
2.7.4.1. Reversed phase chromatography. 
In particular reversed phase chromatography on silica-gel plates, 
coated with silicon oil, was performed according to Biagi et al (1969). 
Pre-coated silica-gel glass plates, 20x20 cm, with and without fluore­
scence indicator (F 254) (Merck A.G.) were used. The plates were 
activated at 120 0 C for half an hour and cooled in a dessicator with 
dry silica-gel. They were then impregnated in a chromatographic 
chamber, containing 200 ml silicon solution. The silicon solution con­
sisted of 5 per cent by weight of silicone MS 200 (350 CS) (Midland 
Laboratories). Acetone/aq.dest 60/40 v/v was used as the solvent 
system. An exception was made for the determinations of the Δ R,,, 
values (see 4.2.4.). In the latter case the ratios from v/v 30/70-85/15 
were used. 
The plates were developed at room temperature over about 15 cm. 
Spots were detected by: 1. Scanning of radioactivity. 2. U.V. absorption 
of spots applied on plates with fluorescence indicator. 3. Spraying 
with a solution of KMn04. This solution was freshly prepared before 
spraying by mixing: 1 per cent KMn0 4 in aq.dest. with an equal 
amount of 5 per cent №2СОз in aq.dest. After spraying, the plates 
were heated for some minutes at 120 0 C. The compounds were 
detected as yellow spots on a violet background. Since lipophilic drugs 
were investigated this method had the advantage of being applicable 
to all of them with significantly different Rf-values. 
2.7.4.2. Determination of radiochemical purity. 
Two portions of radioactive drug (100,000 DPM) were pipetted into 
counting vials and the amount (A) of radioactivity was determined 
(see 2.7.2.). The same amounts were developed on a reversed phase 
plate. After localization by scanning of the radioactive product, silica-
gel with adsorbed compound was scraped off the plate and put in a 
counting flask. To this flask 2 ml aq.dest and 10 ml instagel were 
added. The amount of radioactivity (B) was then determined. The per­
centage of radioactive pure drug was calculated by the formula 
В/АхЮО. 
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2.7.4.3. Determination of percentage unchanged pharmacon in lymph, 
blood and intestinal contents. 
This was performed with the procedures described under 2.7.1.1.В. 
and 4.2.3. The extraction residue was handled according to the proce­
dure mentioned for the determination of radiochemical purity (2.7.4.2.). 
After localization by scanning the developed area was divided into 15 
bands. These bands were scraped off and put into counting flasks. The 
radioactivity was determined in the same way as described under 
2.7.4.2. 
2.7.4.4. Determination of percentages of DDT and aldrin and their 
respective metabolites in perirenal fat. 
These determinations were performed as described in 2.7.1.7. and 
2.7.4.3. except that the extraction residue, before developing on a 
reversed phase plate, was purified by means of an aluminium oxide 
column (see 6.2.2.). 
31 
CHAPTER 3 
FACTORS INFLUENCING THE ABSORPTION OF DDT 
VIA LYMPHATIC AND PORTAL SYSTEMS 
3.1. INTRODUCTION 
In order to determine whether the administration form influences the 
route of drug absorption either via the portal system or via the lymph 
tract, investigations were carried out with DDT in several application 
forms. Much attention has been paid to the fate of this compound in 
the body. Because it is highly lipoid soluble, it accumulates in the fat 
tissues. It has been shown previously that DDT, given in a fatty 
dosage form, is absorbed in considerable amounts via the lymph 
tract (Rothe et al, 1957; Cohn and Sieber, 1970). So DDT is of im-
portance, not only as an accumulating agent, but also as model com-
pound for studying the factors which influence absorption. 
In the present study the following dosage forms were used. 
1. Propylene glycol was employed as the non-fatty dosage form. In 
fact DDT is insoluble in water. So another application form different 
from fat but physiologically inert and miscible with water had to be 
chosen. Propylene glycol is widely used as a non-toxic drug solvent 
(Zaroslinski et al, 1971), and DDT can be dissolved in it. 
2. Triolein was chosen as the fatty vehicle for DDT. It has been shown 
for cholesterol that good rates of lymph transport are reached by 
feeding the sterol dissolved in triolein (Sylvèn and Borgström, 1968). 
It appeared also that DDT can easily be dissolved is this olein. The 
triolein was prefered to the more commonly used vegetable oils (like 
sesam oil) because the latter are not homogeneous but consist of a 
mixture of several components. The experiments with triolein were 
used on rats with and without bile cannulation. 
3. As vehicle of administration in another series of experiments a so 
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called micellar solution was prepared. In the physiological situation fat 
components of the food are transformed to a micellar solution by the 
juices of the gut, before absorption from the lumen of the gut. The 
micellar solution is very important for a good absorption of these 
nutrients. For this reason Gallo-Torres developed a micellar solution 
containing components like conjugated bile salts, lecithin, protein etc. 
to fascilitate maximal absorption of lipoids like vitamin E and choleste­
rol (Gallo-Torres et al, 1969; Gallo-Torres, 1970). The composition of 
our micellar solution was chosen in such a way that it fullfilled as well 
as possible two purposes: 
x. The composition is like that of fats just before absorption by the 
mucosa, in other words is like a natural micellar gut solution (Treadwell 
and Vahouny, 1968; Dobbins, 1969). 
x. The components are present in amounts similar to those in chylomi­
crons (see chapter 5.1.). 
Also in these experiments the possible influence of bile was in­
vestigated by means of cannulation. In addition bile cannulation after 
dosing of micellar solution gives information about entero-hepatic cir­
culation of DDT. The comparison of the absorption of DDT via the 
different dosage forms may give us more information about the 
following question: What must be the properties of the administration 
form in order to give maximal absorption of DDT via the lymph tract? 
An extrapolation with respect to other drugs could be applied and may 
have practical value. 
3.2. MATERIALS AND METHODS 
Cannulation and sampling was carried out as described in chapter 2 
(2.3.2.A.). p,p' - DDT (phenyl-^C) was mixed with unlabelled DDT to a 
specific activity of 1 μΟί/ιτ^. At the start of the experiment each animal 
received 1 mg DDT. As will be shown in chapter 4, in lymph sampled 
from 3-4 hr after administration of DDT (the peak of DDT absorption 
in lymph) 97 per cent of the radioactivity is represented by unchanged 
p,p' - DDT. On this basis it may be assumed that, also during the 
experiments described here, the amount of metabolized DDT is 
negligible. The experimental conditions, in particular with respect to 
the dosage form are given in table 2. 
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Table 2. DDT administration under various experimental conditions. 
exp 
A 
В 
С 
D 
E 
F 
dosage form 
micellar sol 
triolein 
propylene glycol 
triolein 
triolein 
micellar sol. 
4 ml 
0 8 ml 
0 3 ml 
0 3 ml 
0.Θ ml 
4 ml 
bile flow* 
— 
+ 
+ 
+ 
+ 
number of rats 
5 
5 
5 
4 
6 
5 
refers to bile cannulation, which prevents the bile flow. 
Preparation of the micellar solution. 
The composition of 4 ml micellar solution is as follows: 
I. mono olein 
egg lecithin 
cholesterol 
oleic acid 
90 mg 
32 mg 
15 mg 
163 mg 
270 
10 
35 
3 
13.5 
880 
mg 
mg 
mg 
mg 
mg 
mg 
2.65 mi 
II. sodium taurocholate 
sodium taurochenodeoxycholate 
sodium glycocholate 
sodium glycochenodeoxycholate 
sodium chloride 
glucose 
saline 
III. amylopectin 120 mg 
protifar (protein) 32 mg 
The solution is prepared as follows: the fat components give under I 
are weighed in a bottle under N3. The flask is closed and the fat com­
ponents are melted by placing the flask in boiling water. Of this fat 
mixture 300 mg for every portion of micellar solution is weighed in a 
tube already containing DDT-,4C. After dissolving the DDT, the com­
ponents of II are weighed and added to the mixture. This is placed in 
ice and mixed with an ultrasonic disintegrator (M.S.E.) for 50 sec. 
(5 χ 10 sec. with intervals of 1 min.). The pH of the solution is adjusted 
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with HCl to 6.5, the pH of the gut. The two components of III are 
added to the mixture and mixed with an Ultra-Turrax (Janke und 
Kunkel K.GO. 
It was checked that at pH 1.7 (pH in the stomach) this micellar solution, 
diluted with saline 1 : 3, remained clear for 3 hr. 
3.3. RESULTS 
3.3.1. Scheme of absorption. 
The absorption of DDT in the organism is schematized in fig. 4. 
Orally taken DDT is absorbed for a certain part from the gut. Theoreti­
cally the absorption from the gut can be divided into transport via the 
lymph and via the portal system. A certain part of the amount absorbed 
via the portal system is excreted in the gut again via the bile. The 
following symbols are used for the various amounts of DDT present in 
the different body constituents: 
L means the amount of DDT transported via the thoracic duct. This 
amount, measured after collecting during a certain period, is expressed 
as a percentage of the dose (D) administered. 
В means the amount of DDT excreted in bile as a percentage of the 
administered dose. In certain cases the value for В was measured after 
cannulation. Otherwise an approximation was used. 
G means the amount of DDT that remained in faeces, intestinal contents 
and the wall of the gut and stomach. In those experiments in which 
bile flow was not prevented by bile cannulation, the value was correc­
ted for the relatively small amount of DDT, excreted via the bile (B) 
by subtraction. 
do»e D 
gut α 
r 
lymph 
tracb 
L 
' 
portal 
eye tem 
Ρ 
г 
1 
В 
bile 
tract 
blood 
Flg. 4 
Ρ is the amount of DDT absorbed via the portal system diminished 
with the amount of DDT excreted in the bile. P, as a percentage of the 
administered dose was obtained by calculation. The value Ρ can be 
derived with the aid of the following assumption: L + B + G + P = 
100 per cent. 
3.3.2. Excretion of DDT via bile. 
For a good evaluation of the given scheme (fig. 4), it is of importance 
to know to what extent DDT is excreted via the bile. Up to now little 
attention has been paid to this phenomenon. Two different kinds of 
experiments were carried out. In the first series of experiments DDT 
was administered in a micellar solution, containing different bile com­
ponents. In the second series the drug was given in olem preparation. 
At 24 hr after administration the amount of DDT present in the bile, 
collected via cannulation, was determined and this value was compared 
with the amounts present in lymph, portal system and the gut. The 
results are presented in fig. 5. It appeared that in the case of admini­
stration in a micellar solution about 3 per cent of the dose administered 
was excreted via the bile. This amounts to 5.9 per cent of the DDT, 
absorbed via the portal system: B/(P + B). In the second series of 
experiments a quite other pattern was observed. It appears that DDT 
percent oFthe dose.admintatered 
100-1 
DDT ( I r n s ) i n D D T C I m ^ J m 
triolein Oöml micellar öoll . 
Fig 5 
Transport of DDT via different routes in bile - cannulated rats. The amounts of DDT are 
presented as percentages of the doses administered. Means and standard deviations 
are given for 5 separate experiments. L, В and G are the amounts of DDT, measured 
resp in lymph, bile and gut Ρ is the amount of DDT absorbed via the portal system, 
calculated for each experiment as follows: Ρ = 100 per cent - (L + В + G). Samples 
were obtained during or at 24 hr after administration 
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transport via the lymph tract is very low, but a considerable amount 
is absorbed via the portal system. Nevertheless practically no secretion 
with the bile occured. Presumably this is due to a decreased production 
of bile fluid. It can also be observed that in the latter case a great 
amount of DDT was not absorbed from the gut. 
3.3.3. Comparison of the different dosage forms. 
The amounts of DDT absorbed via the different routes in 24 hr de­
pendent on the different dosage forms are summarized in fig. 6. As 
far as the excretion via the bile is concerned, the values given are 
based on an approximation. From the experiment described above 
(3.3.2.), in which DDT was administered in a micellar solution - a good 
imitation of the physiological situation - it was found, that B/(P + B) 
was 5.9 per cent. It was assumed that this ratio also hold true in the 
present cases, in which no bile cannulation was done. So for the ex­
periments presented in fig. 6, the values of В were derived after cal­
culation of P. It was assumed, that no reabsorption of DDT, excreted 
with bile, occured. 
per cent of the dose, administered 
Fig. 6 
Influence of different dosage forms on the transport of DDT via different routes. 
The amounts of DDT are presented as percentages of the doses administered. Means 
and standard deviations are given; η refers to the number of experiments. L is the 
amount of DDT, measured in lymph. G is the measured amount of DDT in the gut, 
corrected for the small amount of DDT excreted via the bile. Ρ Is the amount of DDT 
absorbed via the portal system, calculated for each experiment as follows: Ρ = 100 per 
cent - (L + G measured). В is an approximated value of the amount of DDT transported 
via the bile. Samples were obtained during or at 24 hr after administration. 
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As can be seen in f ig. 6, if DDT is administered in a non-fatty solution 
like propylene glycol, considerably less absorption via the lymphatics 
takes place as compared to the DDT administration in triolein 0.3 ml, 
triolein 0.8 ml and in micellar solution (resp. Ρ < 0.001, Ρ = 0.002, 
Ρ < 0.001 ; F-test). 
However, if a solution of propylene glycol is used, DDT to a greater 
extent is absorbed via the portal system as compared t o triolein 0.3 ml, 
triolein 0.8 ml and micellar solution (resp. Ρ = 0.002, Ρ < 0.001, 
Ρ = 0.001; F-test). The amount of DDT, which is not absorbed, and 
therefore is left in the faeces and other intestinal constituents (G), is 
significantly greater for the group of rats which received DDT in triolein 
0.8 ml as compared with the other groups, namely triolein 0.3 ml, 
micellar solution and propylene glycol (resp. Ρ = 0.004, Ρ = 0.001, 
Ρ = 0.02; F-test). If triolein 0.3 ml and the micellar solution are con­
sidered as dosage forms no obvious differences among the amounts 
of DDT absorbed via the different routes are observed. 
3.3.4. Distribution of DDT absorbed via the portal system. 
In the experiments described up to now, done with lymph-cannulated 
rats, the amount of DDT absorbed via the portal system is deduced 
form measured values. If, indeed, an amount of 1 4C-DDT is transported 
by the blood of the portal vein, then radioactivity must be found in 
the rest of the body and in the urine. Therefore in some rats the amount 
of radioactivity in urine during 24 hr and in blood, liver and perirenal 
fat after 24 hr was investigated. In the experiments the dosage form 
with micellar solution and with propylene glycol was employed (see 
table 3). It appears, that for the micellar solution, as well as for the 
propylene glycol administration, about 0.15-0.20 per cent is present 
in the blood. In the liver the amounts are about 10 times higher. Only 
a small percentage of the absorbed amount is excreted in the urine 
( < 1 percent) . 
It is obvious that a major part accumulates in body fat. In 1 g of 
perirenal fat 1.7 and 1.6 per cent is found, after administration in 
micellar solution and resp. 2.6 and 2.7 per cent after administration 
of 1 4C-DDT in propylene glycol. 
According to the experiments of Reed et al (1930) the total amount 
of fat in the rat can be approached. On the basis of their data 22 g 
of fat can be expected in the rats used by us. It was assumed that the 
radioactive products are present in total body fat in the same ratio 
as in perirenal fat. Thus the amount in total body fat can be derived 
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Table 3 Distribution of radioactivity* m lymph-cannulated rats after 
MC-DDT administration and with calculated absorption by portal blood. 
Vehicle of 
transport 
total blood** 
total liver 
total body fat*»* 
total urine 
sum 
calculated absorption 
by portal blood**** 
Micellar 
solution 
015 
1 3 
37 4 
0 60 
39 45 
50 8 
Micellar 
solution 
015 
1 4 
35 2 
0 70 
37 45 
58 2 
Propylene 
glycol 
015 
22 
57 2 
015 
59 70 
76 2 
Propylene 
glycol 
0 20 
1 5 
59 4 
0 45 
61 55 
70 0 
*
 14C-radioactivity, sampled during or after 24 hr, is given as percentage of the 
administered dose 
** total blood is estimated as 1/15 of body weight 
*** the amount of radioactivity in total body fat Is estimated from the amount In 1 g 
perirenal fat 
**** for the calculation of these values see ch 3 3 1 
from the amount measured in 1 g of perirenal fat. In this way it can be 
calculated that 40-60 per cent product is present m the total body fat. 
As can be seen in table 3 radioactivity was not determined m all parts 
of the body of the rat. Yet, when the given amounts are added and 
compared with the calculated absorption by portal blood, only 10-20 
per cent of the portal absorption cannot be accounted for. After admini-
stration of DDT in propylene glycol the calculated absorption by portal 
blood is about 20 per cent more than after administration m micellar 
solution. This greater amount must be distributed in the body and 
indeed, as can be seen m table 3, the amount of product stored in body 
fat after administration in propylene glycol is about 20 per cent greater 
than after administration in micellar solution. 
3.3.5 Lymphatic absorption of DDT as a function of time. 
In the absorption process of DDT from the intestinal contents to the 
lacteals or portal system two steps can be distinguished· 
1. Absorption of DDT from the intestinal contents to the inside of the 
mucosa cells. 2. Transport of DDT from the mucosa cells to the lacteals 
or the portal system. In principle the dosage form can influence both 
steps. An important question, posed in the introduction (3.1) is to 
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determine whether the dosage form influences the route of drug 
absorption either via the portal system or via the lymph tract. This 
question in fact concerns step 2. namely transport of DDT from the 
mucosa cells to lacteals or portal system. Therefore, in order to get 
an adequate comparison, the results of the lymphatic absorptions 
related to time, are presented as percentages of the total amount of 
DDT absorbed during 24 hr from the gut (Lt/L + Ρ + В). The pattern 
of lymphatic DDT absorption was studied during 24 hr (see fig. 7). 
Lt/L. p. в (%) 
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60 
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n » 5 
βΟ-i 
6 0 -
ад-
2 0 -
DDT (1mg} in triolein О т І 
canulation of bile 
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? 
- ι 1 1 1 1 1 1 Γ-
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12 16 2 0 2 * 16 20 24 
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Influence of dosage forms and bile cannulation on cumulative lymphatic absorption of 
DDT. The amount of DDT, absorbed via the lymph tract (Lt), is presented as a percent­
age of the total amount (L + Ρ + В) absorbed during 24 hr. Means and standard 
deviations are given n refers to the number of experiments 
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The amount of DDT absorbed via the lymph tract (Lt) was determined 
from 0-2, 0-4, 0-8, 0-12 and 0-24 hr after administration 
3 3 5 1 Comparison of different dosage forms 
As is shown in fig 7, the curves of cumulative lymphatic DDT ab-
sorption, obtained after dosing of DDT m micellar solution or m 0 3 ml 
triolein are practically equal However after administration of DDT in 
propylene glycol the lymphatic absorption occurs more slowly and 
the total amount absorbed during 24 hr is lower For all dosage forms 
it can be observed that the absorption is almost completed within 
12-24 hr So 24 hr sampling of lymph seems suitable to obtain a good 
measure for total lymph absorption 
3 3 5 2 Influence of bile cannulation 
Administration of DDT in micellar solution to bile-cannulated rats 
results m a pattern of lymphatic absorption that is fairly comparable 
to the pattern after administration of micellar solution whithout bile 
cannulation This means, that the micellar solution used is a good 
substitute for natural bile and a good imitation of the physiological 
situation is reached In contrast, when DDT is administered in 0 8 ml 
triolein to bile-cannulated rats the lymphatic absorption is very low, 
namelijk 5 1 ± 3 8 (s d ) per cent This means that about 95 per cent 
of the total amount absorbed is transported via the portal system 
3 4 DISCUSSION 
In these investigations several aspects of the absorption of DDT from 
the gut can be clearly recognized As to the question whether the 
administration form influences the route of drug absorption either via 
the portal system or via the lymph tract, the answer is m the affir-
mative As is mentioned in the results (see 3 3 3 and fig 6) if DDT 
is administered m the non-fatty solution propylene glycol, considerably 
less absorption via the lymphatics takes place as compared to DDT 
administered in the fatty dosage forms like triolein and micellar solution 
However, DDT administered in propylene glycol is to a greater extent 
absorbed via the portal system than DDT administered in the mentioned 
fatty dosage forms So it is also clear that DDT, which is highly lipoid 
soluble, is not only absorbed well from a fatty administration form, 
but also from a non-fatty administration form, be it via an alternative 
route 
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From additional experiments in which DDT was administered in a 
non-fatty dosage form like tragacanth it appeared that the apparent 
lymphatic absorption was also low (7.2 per cent). Further it was ob-
served, that in these cases the amount of DDT, which was left unabsor-
bed in the faeces and other intestinal contents was relatively high (61 
per cent) as compared to DDT administered in propylene glycol. 
The finding, that DDT administered in triolein to rats that are bile-can-
nulated, is still absorbed for about 47 per cent, mostly via the portal 
blood (see 3.3.2. and fig. 5) is remarkable. This finding may be inter-
preted with the results of the experiments of Gallagher et al (1965). 
They observed that 0.1 ml of radioactive triolein administered to rats 
with a bile fistula, was absorbed for about 60 per cent. Therefore the 
mentioned absorption of DDT might have occurred together with 
triolein. When DDT is administered in micellar solution to rats that are 
bile-cannulated not only is the portal absorption considerable, but the 
lymphatic transport is also considerable. Only about 10 per cent is 
left unabsorbed in the gut. It might be concluded that besides fat 
components, bile seems to be particularly necessary for lymphatic 
transport of DDT. As to the question which of the dosage forms, 0.3 ml 
triolein or 0.8 ml triolein or micellar solution is best used to give a 
maximal lymphatic absorption of DDT, the answer is as follows: Not 
only the amount of DDT left unabsorbed in the gut is significantly 
greater for DDT, administered in 0.8 ml triolein, but also the pattern of 
lymphatic absorption seems slower and more irregular. Therefore, in 
order to reach maximal lymphatic absorption, the dosage forms 0.3 ml 
triolein and micellar solution have to be used. No difference as to the 
absorption pattern of DDT is seen between these two dosage forms, 
when bile production is normal. 
From the experiments with bile cannulation it might be concluded that 
the micellar solution is preferable in those cases in which normal bile 
flow is absent or disturbed. 
Summarizing it might be stated, that the dosage form can influence the 
route of drug absorption, either via the portal system or via the lymph 
tract. Micellar solution or 0.3 ml triolein can be used equally well as 
dosage form to obtain an optimal lymphatic absorption of DDT. 
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CHAPTER 4 
QUANTITATIVE CORRELATION BETWEEN LYMPHATIC 
ABSORPTION AND FAT SOLUBILITY 
4.1. INTRODUCTION 
As mentioned before, considerable transport of certain pharmaca via 
the lymph tract is known, following oral administration of these phar­
maca in a fatty vehicle. It will be necessary to test more pharmaca in 
order to obtain a clear picture of the principles governing this con­
siderable lymph transport. The pharmaca in respect of which this large 
lymph transport is known are strongly fat soluble. On the other hand 
it has been shown for a number of non - fat soluble medicines that 
they, following oral administration, scarcely penetrate the lymph tract 
at all (Sieber, 1970). Based on these empirical observations the exami­
nation of the degree to which lymph transport can be correlated with 
the measure of fat solubility of a pharmacon is obvious. 
As a measure for the fat solubility of the investigated pharmaca the 
Δ Rm value in respect of butter yellow was dertermined. This term, 
is related to the partition coefficient, i.e. the distribution of the pharma­
con between fat or a fat solvent on one side and water on the other, 
which is generally used as a measure for the lipophilicity of a com­
pound (see 4.2.5.). As a measure of the lymph transport of the phar­
maca studied, the transport in thoracic duct lymph during 24 hr follo­
wing administration was taken. In order to obtain the best possible 
picture of the correlation described, the following points must be taken 
into account: 
- As has already been discussed for the lymphatic absorption of DDT 
(see chapter 3.3.5.) two steps can be distinguished in the absorption 
process of the pharmacon from the intestinal contents to the lacteals 
or portal system: A. Absorption of the pharmacon from the intestinal 
contents to the inside of the mucosa cells. B. Transport of the phar­
macon from the mucosa cells to the lacteals or the portal system. In 
priciple, both steps can be influenced by several factors. Therefore, 
to obtain the correlation between the Δ Rm value and the lymphatic 
absorption of the pharmacon as accurately as possible, the quantity 
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of pharmacon absorbed by the lymph during 24 hr as a percentage of 
the total quantity of pharmacon absorbed from the intestine was taken 
as a parameter for lymphatic absorption. The quantity of a pharmacon 
absorbed from the intestine cannot be exactly determined, because 
to a small extent a pharmacon, already absorbed from the gut, can be 
secreted back again in the gut with bile. Therefore the lymphatic ab-
sorption during 24 hr was expressed as a percentage of "the apparent 
absorbed activity". 
- The question as to whether the lymphatic absorption is complete 
whithin 24 hr after administration of the pharmacon could be ans-
wered by collecting the lymph in several fractions. The pattern of the 
lymphatic absorption of the pharmacon during 24 hr could be ob-
served in the curves of cumulative lymphatic absorption constructed 
from the analysis of these fractions. 
- Either fol lowing oral administration or parenteral administration, phar-
maca are always present to a certain extent in sampled thoracic duct 
lymph, even if these pharmaca are strongly soluble in water. In the in-
troduction (chapter 1.1.A and 1.1.B) this phenomenon has already been 
remarked upon. Both the blood capillaries and lymphatic vessels 
appear to be freely permeable to small molecular weight compounds 
(Landis, 1962) and therefore, soon after administration, different sorts 
of pharmaca appear to be present in blood and lymph in nearly the 
same concentration (Levine et al, 1969). In view of the flow-ratio of 
portal blood and mesenteric lymph, which is approximately 500 (post 
absorptive for the rat) the absorption from the intestine wil l , under 
these circumstances, occur almost solely via the portal tract. Depen-
dent on their pharmaco-kinetic pattern of distribution, metabolism and 
excretion, the pharmacon molecules wil l , fol lowing absorption via the 
portal blood, for some time be present in the circulation to a decreasing 
degree. 
During this time the pharmacon molecules will interchange continuously 
between blood, interstitial tissue fluid and lymph. After the absorption 
from the intestine has been completed, pharmacon molecules from 
the circulation may appear in the thoracic duct lymph and be sampled 
with this. The percentage of the pharmacon absorbed out of the in-
testine which accumulates in the lymph during 24 hr will thus in 
general be related to pharmaco-kinetic parameters, such as the blood 
levels and half-life time of the pharmacon and to the f low of the 
thoracic duct lymph and not directly to the lipophilicity of the phar-
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macón. In a number of investigated cases (Sieben, 1970) this per-
centage appears not to be constant, but to vary between 0.2-8 per 
cent of the quantity absorbed from the intestine. Therefore with a 24 hr 
absorption in the order of 0-8 per cent of the absorbed pharmacon it 
cannot, in general, be attributed to specific absorption via the lymph, 
although specific absorption via this lymph tract can be involved. If 
during the absorption the concentration of the pharmacon in mesen-
teric lymph appears to be many times greater than in portal blood, then 
this provides evidence for specific absorption via the lymph tract. To 
investigate this we have determined the quotient of the concentrations 
in lymph and portal blood during absorption. 
- Practically all the pharmaca in our investigation were labelled with 
14C or 3H. The radioactivity was measured in lymph and blood. Since, 
though, the pharmaca can be metabolized in the body to a certain 
extent, the radioactivity values found, in this case the 24 hr lymph 
absorption and the lymph / portal blood corlcentration, will not only be 
related to unmetabolized pharmacon, but will also include the meta-
bolites. From 9 pharmaca the presence of metabolized and unmeta-
bolized form in lymph- and blood samples was investigated. 
- From the results, described in chapter 3, it appeared that the ab-
sorption of DDT via the lymph tracts was greatest after administration 
in a fatty dosage form. Therefore, in order that the absorption via the 
lymph tract should be as great as possible, the pharmaca were adminis-
tered in 4 ml micellar solution or 0.3 ml triolein. 
4.2. EXPERIMENTAL PROCEDURES 
4.2.1. Animal experiments. 
Two types of animal experiments have been carried out. The technical 
descriptions of these experiments can be found in chapter 2.3.2. 
A. Animal experiments of the first type. 
With the animal experiment of the first type radioactively labelled 
pharmaca were administered into the stomach. After that the radio-
activity in the lymph samples, which were collected up to 24 hr 
after administration, was determined. Radioactivity was also determined 
in the faeces, collected during 24 hr, and in the intestinal contents, 
obtained after 24 hr and in the intestinal wall. It is assumed that the 
total radioactivity, obtained by summation of the activity in faeces, 
intestinal contents and intestinal wall, represents the non-absorbed 
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activity. Since the possibility exists that the activity, already absorbed 
in the body, is again excreted in a small measure with the bile into the 
intestine, we are concerned with an approximated value. By subtracting 
the activity obtained by the above summation from the administered 
activity, the "apparent absorbed activity" was obtained. The activities 
in the lymph samples were always calculated as percentages of the 
"apparent absorbed activity". These lymph samples were collected at 
0-2, 2-4, 4-6, 6-8, 8-12 and 12-24 hr following administration. The activi­
ties measured in the samples are presented cumulatively. Moreover the 
activity of the lymph, collected during 24 hr is presented as a per­
centage of the administered dose. The activities in 24 hr urine and 
in the liver, perirenal fat and intracardial blood after 24 hr were also 
determined. The values found give an impression of the absorption of 
the pharmacon via the portal vein and the distribution in the in­
vestigated tissues and urine. Each pharmacon was tested in at least 
two rats. 
As well as the experiments just described where the pharmaca were 
administered either in micellar solution, or in triolein, some experiments 
were carried out in which the absorption via the lymph tract was studied 
after administration of the pharmacon in an altered administration form. 
B. Animal experiments of the second type. 
After administration of the pharmaca, labelled with 14C and 3H, in 
triolein or micellar solution the samples of mesenteric lymph and portal 
blood were taken at г, 1, 2, 3 and 4 hr following administration. 
The radioactivity per gram lymph or blood was calculated. With the 
help of these values the quotients of the activities in 1 g lymph / 1 g 
portal vein blood could be calculated. As has been described for the 
testing of a number of pharmaca, the lymph, that was collected from 
3 hr 5 min until 3 hr 55 min after administration was used for the 
analytical determination of the percentage of unconverted pharmacon. 
This percentage was also determined in samples of portal blood which 
were collected approximately 4 hr following administration. This deter­
mination was carried out for the pharmaca vitamin D3, DDT, DDE, diel-
drin, quinestrol, mestranol, methylcholanthrene, cyclandelate and 
D.O.P. For all the investigated pharmaca, curves are given for the radio 
activities of the pharmacon in lymph and blood and for the lymph / por­
tal blood concentration quotient after the time intervals mentioned. 
Each pharmacon was tested on 2 rats. Besides the above mentioned 
experiments where the pharmacon was administered into the stomach 
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¡η micellar solution or triolein, other experiments were carried out in 
which the dosage form was altered. In these experiments the percen­
tage of unconverted pharmacon was also determined. In one experi­
ment DDT was administered orally in 0.3 ml propylene glycol. In 
another group of experiments the pharmacon, dissolved in 0.1 ml 
propylene glycol, was injected into the tail vein of the rats. Two hr 
before this injection 0.3 ml triolein was administered, via the stomach 
cannula, to these rats. The last-mentioned experiments were carried 
out with the pharmaca vitamin D3 l DDT, dieldrin, quinestrol and 
mestranol. 
4.2.2. Saponification of D.O.P. and cyclandelate in intestinal fluid. 
The degree to which D.O.P. and cyclandelate are saponified in the 
intestine of the rat was studied by means of the following experiments 
in which saponification values were approximately determined. D.O.P. 
and cyclandelate were saponified in collected intestinal fluid of 2 rats. 
This intestinal fluid was obtained as follows: the rats were brought 
under halothane-N20 narcosis. The abdomen was opened. At a distance 
of 5 cm from the stomach a ligature was applied around the small 
intestine. 4 ml of milk was injected into the stomach and the abdominal 
wall was closed again and the anesthesia terminated. After 1 hr the 
abdominal wall was again opened and a ligature was applied around 
the small intestine directly behind the stomach. The intestinal fluid 
from the piece of intestine, limited by the ligatures, was collected. 
From the 2 rats was collected 4 ml. This mixture was divided between 
2 small containers and brought to 37 0 C. 25 μg radioactive D.O.P., 
dissolved in 5 μΙ. of alcohol was added to one container; in the same 
manner cyclandelate was brought into the other, after which they were 
incubated for 1 hr. The percentages of unconverted product were 
determined in the same way as is discussed for a number of pharmaca 
in lymph and blood in the analytical section. 
4.2.3. Investigated pharmaca. 
In the animal experiments of the first type the pharmaca mentioned 
in table 1, were tested. These are the 14C and 3H labelled pharmaca, 
except for the mentioned cholesterol, phthalic anhydride and vitamin 
D3. Moreover non-radioactive aroclor and hexachlorbiphenyl were in­
vestigated by means of these animal experiments. 
In animal experiments of the second type the same pharmaca that are 
mentioned in table 1, were tested, except for the mentioned cholesterol 
and phthalic anhydride. 
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The Δ Rm value with respect to butter yellow was dertermmed for the 
pharmaca mentioned under chapter 2 6 1. "Non-radioactive com­
pounds", included triolein which is mentioned under the constituents 
of the vehicle 
4 2 4 Analytical procedures 
, 4C and 3H radioactivity were counted as described (chapter 2 7 2 1) 
For DDT, DDE dieldrm, qumestrol, mestranol, vitamin D3, cyclandelate, 
D O P and methylcholanthrene the lymph, portal vein and aorta blood 
were investigated for percentage of unconverted pharmacon as 
follows Firstly the radioactivity was measured m two different parts 
(0 1-0 2 g) as is described in chapter 2 Subsequently an extraction 
according to Bligh and Dyer was employed (chapter 2 7 3 ) on the rest 
(1 g) The obtained chloroform residue contains the lipophilic phar­
macon This chloroform residue was made up to 25 ml with chloroform 
m a measuring flask The incubate of intestinal fluid with D O P or 
cyclandelate was investigated in the same manner The blood- and in­
testine incubate samples were treated as follows 20 ml was reduced 
to a small residue by means of a stream of dry nitrogen and this residue 
was brought onto a reversed phase plate (chapter 2 7 4) as a line 
5 cm long The lymph samples were treated m the same manner, except 
that a duplicate of 5 ml from the measuring flask was handled Pure 
radioactive pharmacon was pipetted onto 2 ml of chloroform from the 
flask and this sample, after reducing by evaporation, was applied 
on the plates as reference This procedure was followed for lymph and 
blood as well as for intestinal incubate All the plates were developed 
m a mixture of 60/40, v/v acetone/water The activity on the plates was 
measured as described The radioactivity of the peak was then mul­
tiplied by 25/20 for the blood samples and the intestinal fluid and by 
25/5 for the lymph The activity obtained, divided by the calculated total 
activity of the sample, multiplied by 100 gave the percentage of un­
converted pharmacon 
4 2 5 Determination of the relative hpophilicity. 
The determination of the degree of hpophilicity of the lipophilic phar­
maca investigated by us as a partition coefficient between water and 
organic liquids is complicated by the extremely low solubility of these 
compounds in water and the high solubility in the organic liquids 
(Boyce and Milborrow, 1965, Van der Kleijn, 1969) Better results are 
obtained with the help of reversed phase chromatography With this the 
so-called Δ Rin value is obtained (Green and Marcmkiewicz, 1963) The 
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following theoretical relationship between partition-coefficient (a) and 
Rf value from liquid-liquid partition chromatography is deduced by 
Martin (1949) 
a = K(1/Rf-1) 
where К = constant for the system. 
Bate-Smith and Westall (1950) introduced the term Rm, where 
Rm = log(1/Rf-1) 
So the relative lipophilicity, Δ Rmi of a pharmacon is finally expressed 
by 
ARm = log(1/Rf.x-1) / 
/(1/Rf,R-1) 
where Rf,x is the Rf value of the pharmacon and 
Rf,R is the Rf value of the reference compound. 
We dertermined the Δ Rm values according to the above method as 
follows: The pharmaca were placed on plates that were respectively 
developed with the developing liquids acetone/water v/v 30/70, 35/65, 
40/60 etc. up to 85/15. This was done for each pharmacon for each 
developing liquid in a multiple of six in so far as the Rf value was > 0 
and < 0.8. The calculated average Rm values were plotted against the 
composition of the developing liquids; the points found generated 
straight lines. Using the developing liquid acetone/water 60/40 an Rm 
value was obtained which occurred on the straight line of the phar­
macon concerned in most cases. By means of this developing liquid the 
Δ Rm value of the pharmaca with respect to butter yellow was deter­
mined. Butter yellow was placed on each plate as a reference. The 
calculation of the Δ Rm value was carried out according to the deduced 
formula: 
Δ Rm = log x'/x. h/h' 
where χ and h represent the distance travelled by respectively phar­
macon and butter yellow, while x' and h' respectively represent the 
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distance of pharmacon and butter yellow from the front of the mobile 
liquid phase The averages and standard deviations obtained from 6 
values are described below with the systematic treatment of the phar-
maca. Exceptions were cortisone and dicumarol, which showed a much 
smaller lipophilicity than the other pharmaca. By extrapolation their 
values were determined at < - 0 3 9 . Hexadecane, vitamins A, E, K,, 
cholesterol, triolein and β sitosterole were also exceptions, showing a 
much greater lipophilicity Their values were determined at > 1.23 by 
extrapolation. The pharmaca were brought on the plate in quantities of 
3 цд or less. The stains were detected in 3 ways as described m 
chapter 2.7.4 1. 
4 3. RESULTS
 H 
с ы Н ^ н Г У с . 
4.3.1. DDT. w ¿a, 
The extensive results from the animal experiment of the first type can 
be found in chapter 3 The following experiment was also carried out 
employing the animal experiment of the first type, in order to examine 
the influence of the administration site of the pharmacon on the extent 
of lymphatic resorption (see table 4): 0.3 ml triolein was administered 
into the stomach of two rats 2 hours before administration of 14C-DDT. 
14C-DDT was dissolved m 0 1 ml propylene glycol and injected into the 
tail vein In the usual way, lymph samples, intestine and faeces were 
collected and the UC activity in these was determined. The extent of 
absorption via the lymph appeared to be small. 
Table 4 14C radioactivity, measured in lymph, faeces and gut after ¡ v. 
injection of ,4C-DDT* m the tail of the rat 
rat 
a 
b 
administered 
amount act 
1 mg 2 5 μΟ 
1 mg 2 5 μΟ 
percentage of the admml 
thoracic duct lymph after 
0-2 2-4 4-8 
002 < 0 0 1 009 
002 003 0 10 
8-12 
0 09 
0 06 
stered am 
hr 
12-24 
0 20 
0 09 
lount collected In 
faeces and 
0-24 gut after 24 hr 
0 40 0 5 
030 05 
* "C-DDT was administered in 0 1 ml propylene glycol, 2 hr before the Injection of 
UC-DDT 0 3 ml triolein was administered in the stomach of the rats 
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The results of the animal experiment of the second type are shown in 
fig. 8. With these experiments 14C-DDT was not only administered 
orally in micellar solution to two rats but also in propylene glycol. In 
addition, ,4C-DDT was administered i.v. dissolved in propylene glycol 
to 1 rat via the tail. In this last mentioned case, 0.3 ml of triolein was 
brought into the stomach 2 hours before the administration. 
In the experiments described in table 4 and fig. 8 total 14C radioactivity 
was measured and no differentiation has been made between the 
parent compound and the metabolites. In order to obtain an impression 
of the percentage of DDT which was metabolized, samples of lymph 
and portal blood were taken in the period of maximal absorption (at 
3-4 hr after oral administration and at г -1 hr after i.v. administration). 
The samples were analyzed for the presence of unmetabolized DDT. 
The values are given in table 5. 
Table 5. The presence of unmetabolized DDT in mesenteric lymph and 
portal blood at 3-4 hr after oral administration (at y2-i hr in case of 
i.v. administration). The values are presented as percentages of total 
14C radioactivity. 
rat 
1 
2 
3 
dosage form 
micel. sol. 
micel. sol. 
prop. glyc. 
route of 
administration 
p.o. 
p.o. 
I.v. 
unmetabi 
lymph 
97 
97 
80 
olized pharmacon (%) 
portal blood 
72 
72 
83 
Reversed phase chomatography revealed a Δ Rm value of 0.38 (s.d. 
0.01). Non-radioactive DDT was detected with U.V. absorption. 
Discussion: 
In chapter 3 an investigation concerning the degree of absorption via 
the lymph, dependent on the oral dosage form, was carried out. It 
appeared that DDT was absorbed to a considerably greater extent via 
the lymph tract following administration in a fatty dosage from (approx. 
50 per cent of the administered quantity), than following administration 
in the non-fatty dosage form propylene glycol (approx. 13 per cent of 
the administered quanatity). The absorption via the portal vein was 
calculated from the results, but was not directly measured. Following 
51 
СЛ 
Ν) 
lymph cone 
doöeilmg· 
in mice! lar 
sol ρ о 
- portal blood cone lymph cone - — 
> ( D P M / ^ - I O 3 (Г>РМ/£-МО ° 
• portal blood cone lymph cone — 
. Í D P M / 5 M O 3 (DPM/g-M03o 
portal blood cone 
m(DPM/g)-103 
(25>*Ci) dose Img ( 2 5 Л І С І ) 
in propylene 5Іусо1 p o 
dose 1 Img- í íS^Ci ) 
in propylene glycol ιν 
cone in lymph/cone in portal blood cone in lymph/cone in portal blood 
5 0 0
 Ί
 r a t i 
rat 2 
-cr-.-u 
cone in lymph/cone in portal blood 
2 5 η 
3 4 
t i m e ( h ) 
3 t 
time ( h ) 
Fig 8 
Concentrations of radioactive compound in mesenteric lymph and portal blood at various 
times after administration of DDT and the corresponding quotients of these con­
centrations The concentrations are given as disintegrations per minute (DPM) per gram 
In the case of I ν administration 0 3 ml triolein was given 2 hr before into the stomach 
the animal experiment of the second type described here, results were 
found (see fig. 8) which can be seen to confirm the results described 
in the 3rd chapter. The portal vein blood indeed appears to contain 
^C-DDT and the concentration of DDT in lymph in respect of portal 
vein blood appears to vary as a function of the dosage form. In the 
introduction to this chapter the fact that the flow ratio of portal vein 
blood and thoracic duct lymph, post absorption, is approximately 500 
in the rat (Landis, 1962) has been discussed. If there is a considerable 
transport of DDT via the lymph tract, then the quotient of the concen-
trations of DDT in lymph and portal vein blood must also be conside-
rable. This indeed appears to be the case. Following oral administration 
in micellar solution this quotient appears to show peak values of 
approx. 300 and 400 respectively, whereas these peak values are 
approx. 100 and 170 respectively, following oral administration of DDT 
in propylene glycol. These results are analogous to the differences in 
absorption via the lymph during 24 hours following administration of 
DDT in fatty and non-fatty dosage form. Following oral administration 
in fat, DDT appears after absorption from the intestine, in the mucosa 
cells and can be absorbed in the chylomicrons and other lipopro-
teins, which have been formed there. This mechanism may be the 
explanation for the relatively large DDT transport. In order to examine 
whether oral administration is necessary for a relatively large transport 
of DDT via the lymph 14C-DDT was dissolved in propylene glycol and 
injected into the tail vein of the rat. Subsequently DDT was detected 
in lymph and portal vein blood samples. By administering triolein 
into the stomach, 2 hours previously in this experiment, we made cer-
tain that, at the moment of injection, the lymph tract was transporting 
a considerable quantity of chylomicrons. In table 4 it can be seen that 
in this case the lymphatic transport of the DDT administered in this 
way was very small over 24 hours ( < 0.5 per cent). 
The conclusion may be drawn that the vehicle as well as the site of 
administration are important for the extent of lymphatic transport. One 
could conclude that little exchange of DDT beween lymph and blood 
occurs. If this were occurring to any great extent, then after oral ad-
ministration one would not be able to find such high values for the 
lymphatic transport of DDT over 24 hours (see chapter 3). These results 
are also confirmed in fig. 8. The concentration of 14C-DDT in the portal 
vein blood after i.v. administration appears to be large in respect to 
the other curves obtained after oral administration. The lymph concen-
tration is also low after i.v. administration and the quotient in lymph/ 
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portal vein blood even appears to be < 20 in the peak values. The 
results mentioned were obtained by measurement of the 14C activity 
following administration of 14C-DDT. Table 5 shows that to a small 
extent metabolites are present in lymph and portal vein blood. It is 
striking that following oral administration the percentage metabolite in 
blood is greater than in lymph. 
The metabolites DDD and DDE from DDT show a considerable 
lipophilicity, as does DDT, but DDE especially shows a completely 
different configurational structure. Whilst DDT and DDD show a 
tetrahedron structure, DDE has a y-shape. Because of the possible 
connection of the structure of the pharmaca with the extent of lymphatic 
absorption, both pharmaca were investigated. 
4.3.2. DDD. "<>{-{>« H-CCI, 
The results from the animal experiment of the first type (chapter 2) are 
shown in fig. 9 and table 6. 
absorption (% ) 
50 Fig 9 
Cumulative absorption of DDD in thoracic duct 
lymph The lymphatic absorption is presented 
as a percentage of the apparent absorption. 
Appa'ent absorption means the amount of the 
administered radioactive pharmacon minus the 
пц amount of radioactivity present m faeces and 
time (h) gut after 24 hr; a, b (etc.) refer to different rats. 20 
Table 6. Radioactivity measured in several biological fluids and tissues 
after oral administration of ^C-DDD. 
rat 
a 
b 
dosage 
form 
triolein 
mie sol 
admims 
amount 
(mg) 
1 
1 
ered percentage of the administered amount of 
act for 24 hr 
(μΟ) faeces urine 
and gut 
% 16 9 13 
% 14 3 0 2 
in after 24 
lymph total 1 g cardiac 
liver blood 
31.1 13 002 
8 9 18 0 04 
ra 
hr 
1 
dloactivity 
In 
g perirenal 
fat. 
2.0 
1 2 
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The results from the animal experiment of the second type (chapter 2) 
are shown in fig. 10. 
The Δ Rm value in respect of butter yellow was found to be 0.26 (s.d. 
0.03). Non-radioactive DDD was detected using UV absorption. 
lymph cone. 
(DPM/g)-W3 о 
1 5 0 η dose. 1mg ( 1,цСІ) 
in mied lar eoi. ρ о. 
1 0 0 
portal blood cone. 
• (DPM/yMO3 
cone in lymph/cone in port«! blood 
2 0 0 -
1 0 0 
Fig. 10 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of DDD 
and the corresponding quotients of these 
concentrations. 
For further details see legend of fig. 8. 
4.3.3. DDE. 
«OÎO« 
C C I , 
The results from the animal experiment of the first type (chapter 2) 
are shown in fig. 11 and table 7. 
absorption ( % ) 
50 
Flg. 11 
Cumulative absorption of DDE in thoracic duct 
β і г іб 20 m l y r i i p h · 
time (h) For further details see legend of fig. 9. 
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Table 7. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-DDE. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act. for 24 hr in after 24 hr in 
form (mg) (μΟ) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat. 
a triolein 1 1 8.5 0 12 41.8 1.3 0.005 2.2 
b mie. sol. 1 1 16 0 0 05 40 8 0.7 0 001 1.1 
The results from the animal experiment of the second type (chapter 2) 
are shown in fig. 12. 
The percentage of unmetabolized DDE at 3-4 hours following oral 
administration is given in table 8. 
The Δ Rm value in respect of butter yellow was found to be 0.44 (s.d. 
0.01). DDE was detected using UV absorption. 
Discussion: 
DDD and DDE appear to be absorbed, similarly to DDT, via the lymph 
tract, to a considerable extent. DDE, which has a different configuratio-
nal structure - namely a y-shape, whereas DDT has a tetrahedron 
structure- but of which the A Rin value is approximately equal to that of 
Fig. 12 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of DDE 
and the quotients of these concentra­
tions. 
For further details see legend of fig 8. 
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lymph cone 
(DPM/j)-103o 
150 τ doae 1ms(1>iCi) 
portal blood cone. 
• ( D P M / y ) 
15 
cone in lymph /cone in portal blood 
200-1 rati 
rat 7 
100 
3 4 
time(h) 
Table 8. The presence of unmetabolized DDE in mesenteric lymph and 
portal blood at 3-4 hr after oral administration (at г-І hr in case of 
i.v. administration). The values are presented as percentages of total 
14C radioactivity. 
rat dosage form 
triolein 
mlcel sol 
route of 
administration 
p o 
po 
unmetabolized pharmacon (%) 
lymph portal blood 
97 
93 
88 
83 
DDT (resp. 0.44 and 0.38), appears in these experiments to be absorbed 
via the lymph tract to approx. the same extent (approx. 45-50 per cent 
of the quantity, absorbed from the intestine). Similar to DDT, the fatty 
tissue appears to bind a considerable amount of DDD and DDE (see 
table 6 and 7). 
Aldnn and its metabolite, the epoxide dieldrm (Wong and Temere, 1965) 
are also strongly lipophilic (Heath and Vandekar, 1964). Therefore 
these pharmaca have also been investigated. 
CI 
CI 
4.3.4. ALDRIN. 
vpti<M 
Cl 
The results from the animal experiment of the first type are shown in 
fig. 13 and table 9. Triolein as well as propylene glycol was used as 
oral administration form. 
50 η 
МП -
30 -
20 -
10 -
A 
^ 
С 
a ' 
b' 
Ц 8 12 16 20 2^ 4 β 12 16 20 ΣΊ 
time (h) 
Fig. 13 
Cumulative absorption of aldnn in thoracic duct lymph A m triolein, В In prop glyc. 
For further details see legend of fig 9 
57 
Table 9 Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-aldrin 
rat dosage 
form 
a triolein 
b triolein 
с triolein 
d prop glyc 
e prop glyc 
f prop glyc 
g prop glyc 
admims 
amount 
(mg) 
ered percent 
act for 
(μΟι) faeces 
and gut 
1 20 5 
1 89 
1 343 
1 23 6 
1 33 2 
1 27 6 
1 27 3 
age of 
24 hr 
urine 
07 
015 
— 
1 3 
1 0 
1 3 
0Θ 
the administered amount of ra 
in after 24 hr 
lymph 
28 5 
23 5 
25 2 
8 0 
59 
66 
70 
total 
liver 
47 
1 7 
33 
32 
33 
5 0 
43 
1 g cardiac 1 
blood 
0012 
0 001 
0 004 
0 02 
— 
0 03 
0 02 
dioactlvity 
in 
g perirenal 
fat 
35 
1 6 
27 
37 
43 
53 
40 
The results from the animal experiment of the second type are shown 
in fig 14 
Δ Rravalue m respect of butter yellow of 060 (s d. 0 15) was obtained 
Non-radioactive aldrm was detected by spraying the chromatography 
plates with KMn0 4 (chapter 2) 
lymph cone • (DPM/s)-103 portal blood cone do«,* lOPM/g)-Vfl 
Imsr (TuCi) 
rn triolein ρ о 
25 
15 
Fig 14 
Concentrations of radioactive compound 
m mesenteric lymph and portal blood at 
various times after administration of al­
drm and the corresponding quotients of 
these concentrations 
For further details see legend of fig 8 
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4.3.5. DIELDRIN. 
ci 
Cl 
Cl 
ICCÜCHJÖ 
Cl 
The results from the animal experiment of the first type are shown in 
fig. 15 and table 10. 
absorption (% ) 
50-, 
MO 
30 
20 -
10 
β 12 16 20 2*» 
time (h) 
Fig. 15 
Cumulative absorption of dieldnn m thoracic 
duct lymph 
For further details see legend of fig 9 
Table 10. Radioactivity measured in several biological fluids and 
tissues after oral administration of 14C-dieldrin. 
rat 
a 
b 
с 
dosage 
form 
triolein 
mie sol 
mie sol. 
administered 
amount 
(mg) 
1 
1 
1 
act 
(μΟ) 
1 
% 
1 
percentage of the administered amount of radioactivity 
for 24 hr 
faeces 
and gut 
148 
38 
128 
urine 
03 
08 
03 
In 
lymph 
137 
89 
9 4 
total 
liver 
27 
2 0 
2 2 
after 24 hr 
1 g cardiac 1 
blood 
0015 
0 003 
0013 
In 
g perirenal 
fat 
47 
27 
37 
The results from the animal experiment of the second type are shown 
in fig. 16. 
The percentage of unmetabolized dieldrin in lymph and portal vein 
blood, 3-4 hr following oral administration and г-І hr following 
administration into the tail vein is shown in table 11. 
0.24 (s.d. 0.01) was obtained as Δ Rm value in respect of butter yellow. 
^C-dieldrin was detected using a radioactivity scanner (see chapter 
2.7.2.2). 
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lymph cone 
(DPM/s).103 о 
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2 5 
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10 
05 
dose ImyOjuCi) 
in propylene glycol 1 v. 
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cone in lymph/cone rnport-al blood 
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Fig 16 
Concentrations of radioactive compound in mesenteric lymph and portal blood at 
various times after administration of dieldnn and the corresponding quotients of these 
concentrations. 
For further details see legend of f ig 8 
Discussion: 
In view of the experiments, which will be described in chapter 6, aldrin 
was administered in triolein as well as in propylene glycol. Like DDT 
(chapter 3) aldrin appears to be absorbed via the lymph tract more 
when administered in a fatty dosage form than when in a non-fatty 
Table 11. The presence of unmetabolized dieldnn in mesenteric lymph 
and portal blood at 3-4 hr after oral administration (at г-І hr in case of 
i.v. administration). The values are presented as percentages of total 
l 4 C radioactivity. 
rat dosage form 
tr iolein 
tr iolein 
prop. glyc. 
route of 
administration 
unmetabolized pharmacon (%) 
lymph portal blood 
p o . 
p o . 
I.V 
9B 
92 
96 
85 
85 
51 
60 
dosage form (respectively about 33 and 10 per cent of the apparent 
absorption). Although the Δ Rm value of aldrin is 0.60 (s.d. 0.15) and 
that of DDT is 0.38 (s.d. 0.01) it appears in these experiments that aldrin 
¡s less absorbed via the lymph tract following oral administration in 
fat (approx. 33 per cent of the apparent absorption). The lymphatic 
absorption is considerable for both, though. 
The Δ Rm value of dieldrin - 0.24 (s.d. 0.01) - is smaller than that of 
aldrin - 0.60 (s.d. 0.15) -. The apparent absorption of dieldrin after 
administration in fatty dosage (about 12 per cent) is also smaller than 
that of aldrin (about 33 per cent). Like DDT, dieldrin, following injection 
into the tail vein whilst the rat is absorbing triolein, appears to show 
a low concentration quotient between lymph/portal vein blood, com­
pared to this quotient following oral fatty administration (see fig. 16). 
Aldrin and dieldrin both appear to be stored to a great extent in the 
fatty tissue (see table 9 and 10). The percentage of unconverted diel­
drin in lymph appears to be greater than in blood, as it also is for 
DDT (see table 11). 
CI α 
α 
4.3.6. LINDANE. ci ct 
The results from the animal experiment of the first type are shown in 
fig. 17 and table 12. 
Fig. 17 
Cumulative absorption of lindane in thoracic 
duct lymph. 
For further details see legend of fig. 9. 
The results from the animal experiment of the second type are shown 
in fig. 18. 
0.06 (s.d. 0.03) was obtained as Δ Rm value in respect of butter yellow. 
Detection was carried out using scanning of the radioactive product. 
• f r 
absorption ( % ) 
5 0 -
-itO-
30-
20-
10-
20 24 
hme(h) 
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Table 12. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-lindane. 
rat 
.a 
b 
dosage 
form 
triolein 
mie sol. 
administered percentage of the administered amount of radioactivity 
amount 
(mg) 
2 
2 
act for 24 hr in 
(μΟ) faeces urine lymph 
and gut 
1 150 158 4 3 
1 18.3 21.6 5.9 
total 
liver 
23 
22 
after 24 hr In 
1 g cardiac 1 g perirenal 
blood fat 
0 02 0.7 
Discussion: 
The Δ Rm value of lindane in respect of butter yellow, 0.06 (s.d. 0.03), 
is smaller than that of the previously considered pharmaca. The 
apparent absorption via the lymph tract during 24 hours (approx. 6 per 
cent) and the quotient of the concentration in lymph/portal vein blood 
(approx. 6 at most) also appear to be smaller. The pharmacon and its 
metabolites are stored less in the fatty tissue and excreted more into 
the urine than is the case for the previously considered pharmaca. 
lymph cone. — (0РМ/£)-Ю3о portal ыооаcone • ( D P M / 5 ) - 1 0 J 
dose VmgWSpCt) 
in triolein ρ о г " 5 
3 Ч 
time ( h ; 
Flg. 18 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
lindane and the corresponding quotients 
of these concentrations 
For further details see legend of fig 8 
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4.3.7. HEXACHLORBIPHENYL AND AROCLOR 
Aroclor is an industrial product. It is a mixture of polychlorbiphenyl-
isomers (PCBs). 
By way of exception these pharmaca were not radioactive. Only the 
animal experiment of the first type was carried out and with that only 
the thoracic duct lymph was analysed. This was done by strongly 
shaking 1 ml lymph for 10 min with 25 ml hexane. After separation of 
the layers 5 microliters of the hexane extract was injected into the 
gas Chromatograph (with E.C.-detector). The following column was 
used: glass, 6' χ %", filled with 3 per cent OV-1 on Gas Chrom. Q, 
80-100 Mesh. Temperature: 190 0 C, carrier-gas: N2 approx. 70 ml/min. 
Data from the animal experiment of the first type; 1 mg of hexachlor-
biphenyl as well as 1 mg of aroclor were separately administered to 
each of 2 rats. The thoracic duct lymph was collected and the percen­
tage of both products was determined. 39.9 per cent of the admin­
istered quantity of hexachlorbiphenyl and 40.0 per cent of the aroclor 
were recovered in the 24 hours lymph. 
0.53 (s.d. 0.01) was obtained as &Rm value of hexachlorbiphenyl in 
respect of butter yellow. It was detected by means of UV fluorescence. 
Discussion: 
Aroclor is a technical product employed in various processes among 
others in dying, and occurs eventually as an environmental pollutant 
(Koeman et al, 1969). It appears to have many properties in common 
with DDT, which is also a chlorinated hydrocarbon, among others may 
be mentioned that it is stored in the body fats for a long time 
(Pichirallo, 1971) .If the absorption of hexachlorbiphenyl is similar to 
DDT which is nearly 100 per cent, then the "apparent absorption" via 
the lymph tract can also be taken to be 39.9 per cent. The relative 
heights of the 12 peaks obtained from aroclor components in the 
chromatogram of the lymph sample did not differ from those of the 
aroclor standard. These aroclor components are PCB-isomers with 
respectively 6, 7 and 8 chlorine atoms per molecule. This result again 
suggests that the lipophilicity of the isomers plays a large role in 
lymphatic transport. 
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4.3.8. HEXADECANE снз-(сн2)-снэ 
The results from the animal experiment of the first type are shown in 
fig. 19 and table 13. 0.3 ml Triolein as well as 0.3 ml liquid paraffin was 
used as dosage form. 
absorption (%) 
β 12 16 20 24 12 16 2 0 ¡к 
time (h) 
Fig. 19 
Cumulative absorption of hexadecane in thoracic duct lymph A- in triolein, B- In liquid 
paraffin 
For further details see legend of fig. 9 
Table 13. Radioactivity measured in several biological fluids and tissues 
after oral administration of ,',C-hexadecane. 
rat 
a 
b 
с 
d 
e 
f 
dosage 
form 
triolein 
triolein 
triolein 
0 3 ml 
liquid 
paraffin 
0 3 ml 
liquid 
paraffin 
0 3 ml 
liquid 
paraffin 
administered 
amount 
(mg) 
20 
20 
20 
20 
20 
20 
act 
(μΟ) 
1 5 
1 5 
1 5 
1 
1 
1 
percentage of the administered amount of 
for 24 hr in after 24 
faeces 
and gut 
31 0 
28 2 
304 
654 
41 5 
72 1 
urine 
0 4 
05 
0 45 
0 14 
0 05 
01 
lymph 
50 0 
491 
44 1 
5 0 
0 5 
1.4 
total 
liver 
0 4 
03 
03 
013 
0 02 
0 05 
1 g cardiac 
blood 
0 004 
0 005 
0 004 
< 0 001 
< 0 001 
< 0 001 
radioactivity 
hr In 
1 g perirenal 
fat. 
0015 
0014 
0 014 
0 032 
< 0 001 
0 01 
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The results from the animal experiment of the second type are shown 
in fig. 20. 
The Δ Rm value appeared to be so large that this could only be found 
to be > 1.23 by means of extrapolation. Detection was achieved by 
scanning the radioactive compound. 
lymph cone. 
30 π гіове:20тсу(1яСІ) 
- portal blood cone 
• ( D P M / g - H O ' 
гЮ 
cone, in lymph /солс-іп portal blood • 
500-
3 M 
time ( h ) 
Fig. 20 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
hexadecane and the corresponding 
quotients of these concentrations. 
For further details see legend of fig. 8. 
Discussion: 
Hexadecane is a component of liquid paraffin. This contains the series 
of saturated aliphatic hydrocarbon chains from C14 up to C26. Until 
now it was assumed that liquid paraffin is not absorbed from the in­
testine. From the experiments described here, it appears that admini­
stration in triolein to the rat results in a considerable absorption, 
whereas administration in liquid paraffin results in a variable but small 
absorption. We must bear in mind, though, that liquid paraffin is used 
as a laxative, naturally in cases where emptying of the intestine is 
incomplete. In such cases the fat, still present in the intestine, could 
promote the absorption of liquid paraffin. By analogy with the above 
mentioned compounds one would expect a considerable accumulation 
of hexadecane in fat. This, though, appears not to occur. It seems 
probable, that this material is metabolized. 
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4.3.9. 3-METHYLCHOLANTHRENE 
The results from the animal experiment of the first type are presented 
in fig. 21 and table 14. 
Fig. 21 
Cumulative absorption of 3-methylcholanthrene 
in thoracic duct lymph 
For further details see legend of fig 9 
Table 14. Radioactivity measured in several biological fluids and tissues 
after oral administration of ,4C-metylcholanthrene. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act for 24 hr In after 24 hr In 
form (mg) (μΟ) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat 
a triolein 1 1 40 5 6 5 14 6 0.7 0 008 0 027 
b triolein 1 1 5 51 0 — 188 1.0 0 022 0023 
The results from the animal experiment of the second type are shown 
in fig. 22. 
The percentage of unmetabolized methylcholanthrene at 3-4 hr following 
oral administration is given in table 15. 
0.25 (s.d. 0.03) was obtained as Δ Rm value in respect of butter yellow. 
Detection was carried out by spraying with KMn04. 
Discussion: 
Methylcholanthrene is an aromatic hydrocarbon with carcinogenic 
activity. Its Δ Rm value in respect of butter yellow (0.25) is identical to 
that of dieldrin (0.24) and its lymphatic transport is considerable, 
50 η 
12 16 20 2k 
time(h> 
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Fig 22 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
3-methylcholanthrene and the corres­
ponding quotients of these concentra­
tions 
For further details see legend of fig. 8. 
(24-38 per cent of the apparent absorption). In thoracic duct lymph, 
concentrations up to 200-300 times greater than the concentration in 
portal vein blood are reached (fig. 22). The question arises whether, 
due to high concentration of the transported methylcholanthrene, car­
cinomas develop to a greater extent m the walls of the lymph vessels 
and lymph nodes in the intestinal area and m the thoracic duct. Against 
all expectations this compound, like hexadecane, is slightly absorbed 
into body fat. Here the percentage of metabolite is also larger in blood 
than in lymph (table 15). 
Table 15. The presence of unmetabolized 3-methylcholanthrene in 
mesenteric lymph and portal blood at 3-4 hr after oral administration 
(at Уг-І hr m case of i.v. administration). The values are presented as 
percentages of total UC radioactivity. 
rat 
1 
2 
dosage form 
triolein 
triolein 
route of 
administration 
po. 
p o 
unmetabolized 
lymph 
83 
85 
pharmacon (%) 
portal blood 
70 
49 
67 
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4.3.10. Δ 1-TETRAHYDROCANNABINOL 
The results of the animal experiment of the first type are shown in 
fig. 23 and table 16. 
16 20 74 
time (h ) 
Fig. 23 
Cumulative absorption of Δ 1-tetrahydrocanna­
binol in thoracic duct lymph. 
For further details see legend of fig. 9. 
Table 16. Radioactivity measured in several biological fluids and tissues 
after oral administration of 3Η-Δ 1-tetrahydrocannabinol. 
rat 
a 
Ь 
dosage 
form 
triolein 
mie. sol. 
administered 
amount act. 
(mg) (μΟ) 
0 020 
0.020 
10 
10 
percentage of the administered amount of radioactivity 
for 24 hr in after 24 hr in 
faeces urine 
and gut 
32.2 11.9 
36 8 13.0 
lymph total 
liver 
9.8 1.5 
9.8 0.9 
1 g cardiac 1 g perirenal 
blood fat. 
0.11 0.13 
0.10 0.07 
The results of the animal experiment of the second type are shown in 
fig. 24. 
0.43 (s.d. 0.03) was obtained as Δ Rm value in respect of butter yellow. 
Detection was achieved by scanning the radioactive compound. 
Discussion: 
Δ 1-THC is an active primary constituent of marihuana. The Δ Rm value 
of Δ 1-THC (0.43) is greater than that of DDT (0.38). The transport via 
the lymph tract is considerable (approx. 15 per cent of the apparent 
absorption) but not as large as from DDT (approx. 50 per cent). The 
storage in perirenal fat is small. A relatively large excretion via the 
urine (see table 16) is explicable from the fact that this lipophilic 
pharmacon is to a considerable extent converted in the body to more 
hydrophilic products (Vree et al, 1972). 
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Fig 24 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
Δ 1-tetrahydrocannabinol and the corres­
ponding quotients of these concentra­
tions 
For further details see legend of fig 8. 
4.3.11. VITAMIN D3 
The animal experiment of the first type has not been carried out by us. 
In the literature one can find results of analogous experiments. 
Schachter et al (1964) found after oral administration in a fatty vehicle 
absorption via the intestinal lymph tract of 75-100 per cent of the 
apparent absorption. 
Results of the animal experiment of the second type are shown in 
fig. 25. 
The percentage of unconverted pharmacon 3-4 hr following oral 
administration and г-І hr following administration into the tail vein is 
shown in table 17. 
1.23 (s.d. 0.12) was obtained as Δ Rm value in respect of butter yellow. 
Detection was carried out by means of spraying with KMnO<. 
Discussion: 
The large lymphatic transport and the large concentration quotient of 
vitamin D3 in lymph/portal vein blood agree with a high Δ R,,, value of 
vitamin D3 in respect of butter yellow. Now we see again that the con-
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Fig. 25 
Concentrations of radioactive compound in mesenteric lymph and portal blood at 
various times after administration of vitamin D3 and the corresponding quotients of 
these concentrations. 
For further details see legend of fig 8. 
centration quotient of vitamin D3 in lymph/portal vein blood following 
intravenous administration in propylene glycol, when 0.3 ml triolein 
has been orally administered 2 hr previously, is small (approx. 9) 
compared to this quotient (peak value approx. 244) obtained following 
oral administration. Also the quantity of metabolite in portal vein blood 
is greater here than in lymph. 
Table 17. The presence of unmetabolized vitamin D3 in mesenteric 
lymph and portal blood at 3-4 hr after oral administration (at г-І hr in 
case of i.v. administration). The values are presented as percentages 
of total ^ C radioactivity. 
rat dosage form 
triolein 
prop. glyc. 
route of 
administration 
p.o. 
i v. 
unmetabolized pharmacon (%) 
lymph portal blood 
90 
86 
27 
57 
70 
Vitamin D3 has a structural affinity with cholesterol. Because of this 
structural affinity with sterols and steroids, the steroids quinestrol, 
mestranol, progesterone, nandrolone and lynestrenol are now con­
sidered. 
4.3.12. QUINESTROL 
CH, OH 
^ C^CH 
The results of the animal experiment of the first type are shown in 
fig. 26 and table 18. 
abeorption (% ) 
16 20 -24 
time (.h) 
τ r 
16 20 24 
t ime(h) 
16 20 24 
time ( h ) 
Fig. 26 
Cumulative absorption of quinestrol In thoracic duct lymph. A: in tr iolein; B: In mie. sol. 
C: in mono- and triolein (25/75). 
For further details see legend of f ig. 9. 
The results of the animal experiment of the second type are shown in 
fig. 27. 
The percentage of unconverted pharmacon 3-4 hr following oral ad­
ministration and г-І hr following administration into the tail vein is 
shown in table 19. 
0.24 (s.d. 0.03) was obtained as Д Rm value in respect of butter yellow. 
Detection was carried out using KMn0 4 spraying. 
Discussion: 
The Δ Rm value in respect of butter yellow for quinestrol (0.24) is equal 
to that of dieldrin (0.24). The extent of lymphatic transport of the phar-
maca is nearly identical. Other authors have investigated the extent 
of absorption of quinestrol via the thoracic duct (Giannina et al, 1967). 
They found a higher lymphatic transport of quinestrol when administe­
red in sesame-oil, containing 25 w/v per cent monoolein, than after 
administration in sesame-oil alone. We can confirm their results for 
the triolein administration form. In our investigation it is approx. 10 
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Table 18. Radioactivity measured in several biological fluids and tissues 
after oral administration of 3H-quinestrol. 
rat dosage amount act 
form 
administered percentage of the administered amount of radioactivity 
for 24 hr m after 24 hr in 
(mg) (μΟ) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat 
triolein 
triolein 
triolein 
mie sol 
mie sol 
mie sol 
mono- and 
triolein, 25/75 
h mono- and 
triolein, 25/75 
0 020 
0 020 
0 020 
0 020 
0 020 
0 020 
0 020 
0 020 
5 
5 
5 
5 
10 
10 
37 0 
50 9 
45 1 
53 5 
48 2 
48 6 
53 1 
60 7 
75 
65 
20 
59 
56 
25 
85 
28 
98 
11 4 
101 
70 
88 
101 
2 6 
35 
1 8 
1 4 
1 9 
1 8 
79 32 
82 30 
0 02 
0 03 
0 03 
0 01 
0 02 
0 04 
0 03 
0 02 
03 
03 
03 
0 25 
03 
05 
03 
03 
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Fig 27 
Concentrations of radioactive compound in mesenteric lymph and portal blood at 
various times after administration of quinestrol and the corresponding quotients of these 
concentrations 
For further details see legend of fig 8 
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Table 19 The presence of unmetabolized quinestrol in mesenteric lymph 
and portal blood 3-4 hr after oral administration (at '/2-1 hr in case of 
ι ν administration) The values are presented as percentages of total 
14C radioactivity 
rat 
1 
2 
3 
dosage form 
micel sol 
mice! sol 
prop glyc 
route of 
administration 
p o 
po 
ι V 
unmetabolized 
lymph 
93 
83 
81 
pharmacon (%) 
portal blood 
43 
43 
45 
per cent of the administered quantity in lymph (table 18), in their 
results, after administration in sesame-oil, the value was 7 5 per cent 
of the administered quantity They found 15 7 per cent of the admini­
stered quantity in the thoracic duct lymph, following administration m 
sesame-oil, containing 25 w/v per cent monoolem, we do not find this 
increase following administration in tnolem/monoolein 75/25 w/w We 
also did not obtain a lymphatic transport increase by administration 
m micellar solution Here again the percentage metabolite is greater 
m blood than in lymph (table 19), also the concentration quotient of 
quinestrol m lymph/portal vein blood is smaller following ι ν admini­
stration of quinestrol (peak value approx 4) than following oral ad­
ministration (peak value 40-50) 
4 3 13 MESTRANOL 
The results of the animal experiment of the first type are shown m 
fig 28 and table 20 
Fig 28 
Cumulative absorption of mestranol In thoracic 
duct lymph 
For further details see legend of fig 9 
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Table 20. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-mestranol. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act for 24 hr in after 24 hr In 
form (mg) (μΟ) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat 
a mIс sol 0 030 
b mie sol 0 030 
с mie sol 0 030 
d mie sol 0 030 
1 
1 
2 
1 
56 7 
157 
67 0 
185 
— 
3 6 
— 
70 
0 67 
0 46 
0 35 
0 95 
0 6 
07 
— 
01 
0 008 
0 001 
0012 
0017 
0 006 
The results of the animal experiment of the second type are shown in 
fig 29. 
The percentage of unconverted pharmacon, 3-4 hr following oral ad­
ministration and УгИ hr following administration into the tail vein is 
shown in table 21. 
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Fig 29 
Concentrations of radioactive compound in mesenteric lymph and portal blood at 
various times after administration of mestranol and the corresponding quotients of these 
concentrations 
For further details see legend of fig 8 
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Table 21 The presence of unmetabolized mestranol in mesenteric 
lymph and portal blood at 3-4 hr after oral administration (at Уг-І hr in 
case of ι v. administration). The values are presented as percentages 
of total 14C radioactivity. 
rot 
1 
2 
3 
dosage 
micel 
mlcel 
prop 
form 
sol 
sol. 
g lye 
route of 
administration 
p o 
p o 
1 V 
unmetabolized 
lymph 
72 
70 
64 
pharmacon (%) 
portal blood 
26 
14 
37 
0.08 (s.d. 0 06) was found as Δ Rm value m respect of butter yellow. 
Detection was carried out using KMn0 4 spraying. 
Discussion: 
Qumestrol is the cyclopentylether of ethynyl estradiol. Mestranol is the 
methylether of ethynyl estradiol. So the compounds only differ m the 
cyclopentyl and m the methyl component The Δ Rm value descreases 
considerably due to this, though. We also find a small apparent absorp­
tion via the thoracic duct lymph and a small concentration quotient in 
lymph/portal vein blood. The percentage of metabolite is again greater 
in blood than m lymph (table 21). 
4.3.14. PROGESTERONE 
The results of the animal experiment of the first type are shown in 
fig. 30 and table 22. 
abeorption ( % ) 
5 
16 20 24 
time (h) 
Fig 30 
Cumulative absorption of progesterone in 
thoracic duct lymph 
For further details see legend of fig 9 
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Table 22. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-progesterone. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act for 24 hr in after 24 hr In 
form (mg) (μΟ) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat. 
a mlc sol 4 1 36 1 3 9 0 27 011 < 0 001 < 0 001 
b triolein 4 1 47 0 6 9 0 37 0 4 < 0 001 0 006 
The results of the animal experiment of the second type are shown in 
fig. 31. 
The Δ Rm value in respect of butter yellow was found to be -0.18 (s.d. 
0.05). Detection was carried out using KMn0 4 spraying. 
Fig 31 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
progesterone and the corresponding 
quotients of these concentrations 
For further details see legend of fig 8 
4.3.15. NANDROLONE 
The results of the animal experiment of the first type are shown in 
fig. 32 and table 23. 
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Fig 32 
Cumulative absorption of nandrolone in thoracic 
duct lymph 
For further details see legend of fig 9 
Table 23. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-nandrolone. 
rat 
a 
b 
dosage 
form 
triolein 
mie sol 
administered percentage of the administered amount of radioactivity 
amount 
(mg) 
0 440 
0 440 
act for 24 hr in 
(μΟ) faeces urine lymph total 
and gut liver 
1 487 171 07 08 
1 549 150 0 8 0 5 
after 24 hr in 
1 g cardiac 1 g perirenal 
blood fat 
001 002 
001 002 
The results of the animal experiment of the second type are shown in 
fig. 33. 
The Δ Rm value m respect of butter yellow was found to be -0 39 (s d. 
0.04) Detection was carried out using KMn0 4 spraying. 
lymph cone -— (DPM/3-HO3 о 
3 dote MWmcgtfjjCi) 
in triolein ρ о 
-portal blood cone 
• ( D P M / s ) - 1 0 3 
3 U 
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Fig 33 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of nan­
drolone and the corresponding quotients 
of these concentrations 
For further details see legend of fig 8 
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4.3.16. LYNESTRENOL 
с=сн 
The results of the animal experiment of the first type are shown in 
fig. 34 and table 24. 
absorption ( % ) 
50-
W-
30-
20-
10-
^S 12 16 20 24 
t ime(h) 
Fig 34 
Cumulative absorption of lynestrenol in thoracic 
duct lymph 
For further details see legend of fig 9 
Table 24. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-lynestrenol. 
rat 
a 
b 
dosage 
form 
mie sol 
triolein 
administered 
amount act 
(mg) (μΟ) 
35 
35 
05 
0 5 
percentage of the administered amount of radioactivity 
for 24 hr in 
faeces urine lymph total 
and gut liver 
541 111 3 2 0 5 
26 4 40 7 6 2 12 
after 24 hr in 
1 g cardiac 1 g perirenal 
blood fat 
< 0 001 0 04 
O i l 0 04 
The results of the animal experiment of the second type are shown in 
fig. 35. 
The Δ Rm value in respect of butter yellow was found to be 0.44 (s.d. 
0.05). Detection was carried out using КМПО4 spraying. 
Discussion: 
The Δ Rm value of lynestrenol in respect of butter yellow is relatively 
high. Therefore we find a larger lymphatic transport compared to the 
previous, much less lipophilic, steroids nandrolone and progesterone. 
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Fig 35 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
lynestrenol and the corresponding 
quotients of these concentrations 
For further details see legend of fig 8 
The results of the animal experiment of the first type are shown in 
table 25 
For rat a (table 25) the percentage of the apparent absorption, that was 
absorbed via the lymph tract, was from 0-12 hr after administration 0 49 
per cent and from 12-24 hr after administration 0.01 per cent. So, in 
24 hr this absorption was 0 50 per cent. 
For rat b (table 25) these percentages were from 0-12 hr 0 40 per cent, 
and from 12-24 hr 0 10 per cent So, m 24 hr this absorption was 0 50 
per cent. 
Table 25 Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-diethylstilbestrol. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act for 24 hr in after 24 hr in 
form (mg) (μΟ) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat 
a mie sol 0100 1 454 10 027 12 < 0 0 0 1 < 0 0 0 1 
b triolein 0100 1 57 3 18 0 21 12 < 0 001 < 0 001 
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4.3.17 DIETHYLSTILBESTROL 
The results of the animal experiment of the second type are shown in 
fig. 36. 
The Δ Rm value in respect of butter yellow was found to be -0 07 (s d. 
0.03). Detection was carried out using КМПО4 spraying 
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(DPn/g)-103o 
— portal blood cone 
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3 4 
time (hj 
Fig 36 
Concentrations of radioactive compound 
m mesenteric lymph and portal blood at 
various times after administration of 
diethylsti lbestrol and the corresponding 
quotients of these concentrations 
For further details see legend of f ig 8 
4.3.18. CYCLANDELATE 
~ но О J L 5 , 
C H 3 
The results of the animal experiment of the first type are shown in 
fig. 37 and table 26 
аЬвогрІюп (%) 
10-
β-
6-
4 -
2 -
12 16 20 2h 
time ( h ) 
Fig 37 
Cumulative absorption of cyclandelate In thora­
cic duct lymph 
For further details see legend of f ig 9 
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Table 26. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-cyclandelate. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act. for 24 hr In after 24 hr In 
form (mg) (цСі) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat. 
a mie. sol. 2 0.5 1.2 79 3 1.6 0.07 0.003 0.04 
Ь triolein 2 0.5 0.5 64.0 1.3 0.8 < 0.001 0.03 
The results of the animal experiment of the second type are shown in 
fig. 38. 
The percentage of unconverted pharmacon 3-4 hr following oral ad­
ministration and г-І hr following administration into the tail vein is 
shown in table 27. 
The Δ Rm value in respect of butter yellow was found to be 0.18 (s.d. 
0.04). Detection was carried out using KMn0 4 spraying. 
Discussion: 
The ARm value of this ester, 0.18, is lower than that of dieldrin 
(0.24) or quinestrol. Cyclandelate appears to be saponified in lymph 
Fig. 38 
Concentrations of radioactive compound 
In mesenteric lymph and portal blood at 
various times after administration of 
cyclandelate and the corrspondlng 
quotients of these concentrations. 
For further details see legend of fig. 8. 
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Table 27. The presence of unmetabolized cyclandelate in mesenteric 
lymph and portal blood at 3-4 hr after oral administration (at Уг-І hr 
in case of ¡.v. administration).The values are presented as percentages 
of total 14C radioactivity. 
rat dosage form route of 
administration 
unmetabolized pharmacon (%) 
lymph portal blood 
triolein 
triolein 
p.o. 
p.o. 
26 
34 
10 
9 
and even more so in the blood. Therefore an experiment was carried 
out to determine whether the saponification had already occurred to 
a considerable extent in the intestine. Cyclandelate appears not to be 
converted to any great extent in the intestinal contents. Approx. 20 per 
cent of the initial amount appeared to be hydrolyzed following 1 hr in-
cubation in intestinal fluid of the rat. 
CHj 
о сн2 II I C- O-CHj-CH- CHj CHj- CHj- CH, 
C - O - C H J - C H - CHf CHJ- cHi-CHj 
о 
4.3.19. DIOCTYLPHTHALATE 
CH2 I 
CH, 
The results of the animal experiment of the first type are shown in 
fig. 39 and table 28. 
absorption (%> ) 
10 -, 
Fig. 39 
Cumulative absorption of dioctylphthalate In 
_ 1
 ' ι thoracic duct lymph. 
Û 12 16 20 2A 
hme(h) For further details see legend of fig. 9. 
The results of the animal experiment of the second type are shown in 
fig. 40. 
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Table 28 Radioactivity measured m several biological fluids and tissues 
after oral administration of ,4C-dioctylphthalate. 
administered percentage of the administered amount of radioactivity 
rat dosage amount act for 24 hr in after 24 hr In 
form (mg) (μΟί) faeces urine lymph total 1 g cardiac 1 g perirenal 
and gut liver blood fat 
a triolein 1 1 33 0 42 2 1 9 2 2 — 0 02 
b triolein 1 1 33 5 22 3 3 2 2 1 0 02 0 04 
с triolein 1 1 119 25 В 0 8 16 — 0 01 
The percentage of unconverted product 3-4 hr following oral admini­
stration and Уг-І hr following administration into the tail vein is shown 
in table 29. 
The ДП
Ш
 value in respect of butter yellow was found to be > 1.23 by 
extrapolation. Detection was carried out using UV absorption. 
Discussion: 
D.O.P. is much used as a softener in plastics. Blood that was stored 
in plastic infusion bottles appeared to extract D.O.P. from the plastic 
(Jaeger and Rubin, 1970) Thus D.O.P. appeared in the infused body 
lymph cone — por+al blood cone. 
cone in lymph/cone in portal blood 1 
10-1 nat 1 
rat 2 
1 2 3 4 
time (h) 
Fig. 40 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of 
dioctylphthalate and the corresponding 
quotients of these concentrations 
For further details see legend of fig 8 
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Table 29. The presence of unmetabolized dioctylphthalate in mesenteric 
lymph and portal blood at 3-4 hr after oral administration (at Va-1 hr 
in case of i.v. administration). The values are presented as percentages 
of total 14C radioactivity. 
rat 
1 
2 
dosage form 
triolein 
prop. glyc. 
route of 
administration 
p.o. 
p.o. 
unmetabolized 
lymph 
65 
78 
pharmacon (%) 
portal blood 
21 
23 
and the unconverted product was demonstrated by gas chromato­
graphy. The Δ Rm value in respect of butter yellow appears to be 
large. This ester, though, appears already to be markedly saponified in 
the intestine. Incubation of D.O.P. for 1 hr with intestinal fluid produced 
a saponification of 79 per cent. The lymphatic absorption appeared to 
be small and the lymphatic/portal blood cone, quotient was also low. 
Finally the perirenal fat appeared to absorb only a small amount of 
radioactivity and the excretion via the urine appeared to be conside­
rable, which one might expect from a hydrophilic metabolite. In con­
clusion it can be said that following oral administration of D.O.P. there 
is less danger of absorption of the product in the body than following 
parenteral administration. Also for this material the percentage of 
metabolite appears to be larger in portal vein blood than in lymph. 
4.3.20. DICUMAROL 
The results of the animal experiment of the first type are shown in 
fig. 41 and table 30. 
Fig. 41 
Cumulative absorption of dicumarol In thoracic 
duct lymph. 
For further details see legend of fig. 9. 
ccc;jpo 
«beorption (% ) 
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Table 30. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14C-dicumarol. 
rat 
a 
b 
dosage 
form 
mie. sol. 
mie. sol. 
administered 
amount act. 
(mg) (μΟ) 
1 
1 
1.5 
1.5 
percentage of the administered 
for 24 hr in 
faeces 
and gut 
22.4 
10.0 
urine lymph total 1 
liver 
12.7 12.4 5.3 
10.4 11.6 2.6 
amount of radioactivity 
after 24 hr in 
g cardiac 1 g perirenal 
blood fat. 
0.3 0.1 
0.2 0.1 
The results of the animal experiment of the second type are shown in 
fig. 42. 
The Δ Rm value in respect of butter yellow was found to be < -0.39 
by extrapolation. Detection was carried out using KMn0 4 spraying. 
lymph cone. portal blood cone. 
(DPM/gMO'o · ( D P M / j H O 3 
SO-, Я dose ImgtfSMO) г 50 
¡nmicellar sol po. 
HO 
30 
1 2 0 
3 U 
time ( h ) 
f ig. 42 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of dicu-
marol and the corresponding quotients 
of these concentrations. 
For further details see legend of fig 8. 
Discussion: 
Dicumarol has a very low Δ Rm value, moreover this compound is 
practically insoluble in water. It has a large protein binding capacity. 
The lymphatic/portal blood cone, quotient appeared to be practically 1. 
Still the lymphatic transport of dicumarol and its metabolites continues 
regularly up to 24 hr following administration. The concentration in 
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cardiac blood appears to be considerable. Probably a great part of 
the dicumarol, transported via the lymphatic tract, is extracted from the 
blood vessels by equilibrium exchange between the blood and the 
tissues. So this lymphatic transport of dicumarol does not represent 
the direct absorption out of the intestine to the lymph vessels. 
4.3.21. ρ - DIMETHYLAMINOAZOBENZENE 
= BUTTER YELLOW O-N-N-Q-NSHA 
The results of the animal experiment of the first type are shown in 
fig. 43 and table 31. 
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Fig 43 
Cumulative absorption of p-dimethylammoazo-
benzene in thoracic duct lymph 
For further details see legend of fig 9 
Table 31. Radioactivity measured in several biological fluids and tissues 
after oral administration of 14-p-dimethylammoazobenzene. 
rat 
a 
b 
dosage 
form 
triolein 
mie sol 
administered percentage of the administered 
amount 
(mg) 
2 
2 
act for 24 hr in 
( μ Ο ) faeces urine lymph total 1 
and gut liver 
0 5 8 0 72 4 2 5 1 0 
0 5 12 3 80 5 2.2 0 5 
amount of radioactivity 
after 24 hr in 
g cardiac 1 g perirenal 
blood fat 
0 1 0 03 
0 1 0 01 
The results of the animal experiment of the second type are shown in 
fig. 44. 
The ARm value in respect of butter yellow is zero by definition. Detec­
tion was by visual examination since the compound is coloured. 
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Fig. 44 
Concentrations of radioactive compound 
in mesenteric lymph and portal blood at 
various times after administration of p-
dimethylamlnoazobenzene and the cor­
responding quotients of these concen­
trations. 
For further details see legend of fig. θ 
4.4. CONCLUDING REMARKS 
The experimental results, as described above, clearly demonstrate that 
there is a selective lymph absorption of various compounds including 
some insecticides, halogenated hydrocarbons, a carcinogen such as 
methylcholanthrene and other pharmaca. This lymphatic transport par­
ticularly occurs when these compounds are administered in a fatty 
dosage form (chapter 3). This selective absorption can also be inferred 
from the great concentration of these pharmaca in the lymph fluid, at 
the peak of the absorption process, compared with the concentration in 
the portal blood. So, for instance, the concentration quotients (lymph/ 
blood) for compounds which show an apparent lymphatic absorption 
during 24 hr of 10-20 per cent, are in the range of 30-100; however for 
compounds absorbed for more than 20 per cent via the lymph these 
quotients amount to 100-400. This is in good agreement with the dif­
ference in flow rate between lymph and portal blood as already men­
tioned in chapter 1. 
Dicumarol is in this respect an exception. Although the amount of 
dicumarol measured in the 24 hr lymph is considerable, namely 13-16 
per cent of the total amount absorbed from the gut, the lymph/blood 
concentration ratio appears to be only about 1. It must also be remar­
ked, that the lymphatic transport of dicumarol gradually increases 
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during 24 hr (see fig. 41) in contrast to the other compounds studied, 
which show a maximum in their transport after 1-4 hr. For dicumarol 
the possibility exists that as well as a direct absorption via the lymph 
vessels, this drug also appears in the lymph via a redistribution from 
the blood. 
As to the question posed in the introduction (4.1), whether there is 
any relationship between the lymphatic transport of a pharmacon and 
its lipid solubility, it is striking that only those compounds with a high 
lipophilicity are absorbed via the lymph tract to any considerable 
extent. For the different compounds investigated, the degree of cor­
relation between lymphatic transport and lipophilicity was studied 
quantitatively. As is shown in fig. 45, it appears that there exists a 
log % absorption 
2-, 
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The correlation between the apparent lymphatic absorption and lipid solubility. The 
apparent lymphatic absorption is presented as the percentage of the amount absorbed 
during 24 hr from the gut. The lipid solubility of the pharmaca is expressed as a Δ R 
value relative to butter yellow (4.2.4). 
(1) DDT, (2) DDD, (3) DDE, (4) aldrin. (5) dieldrin, (6) lindane, (7) hexachlorbiphenyl. 
(9) methylcholanthrene, (10) ΔΙ-THC, (12) quinestrol, (13) mestranol, (14) progesterone, 
(15) nandrolone, (16)lyne8trenol, (17) diethylstilboestrol, (18) cyclandelate, (21) p-
dimethylaminoazobenzene = butter yellow, (22) testosterone, (23) methvltestosterone. 
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linear correlation between the log of the apparent lymphatic absorption 
and the Δ Rm values of the different pharmaca relative to butter yellow. 
The relationship can be characterized by the following equation 
log % absorption = 2.01 ( ± 0 63) Δ Rm + 0 50 ( ± 0 20) 
η = 19 r = 0850 s = 0380 
where r is the correlation coefficient 
s represents the standard deviation 
η refers to the number of different compounds tested. 
In the equation the 95 per cent confidence intervals are 
given by the figures in parentheses 
From the data given above it appears that there is a reasonable cor­
relation Within a limited range of strong hpophilicity it is permissible 
to conclude that greater hpophilicity results m a greater lymphatic 
transport. This is m contrast to the conclusion of Levine (1969), that 
the degree of lipid solubility may only determine the degree of total 
absorption from the intestine but not the proportion of absorbed 
material leaving via the lymph. The conclusion of Levine, however, was 
only based on studies with quaternary ammonium compounds, which 
are less lipid soluble than the pharmaca used m our study 
Nevertheless, on the basis of the results of the present correlation 
study, it cannot be excluded that, as well as the hydrophobic character 
of the compounds, other properties (electronic, stereochemical) also 
play a role in lymphatic absorption In chapter 5 it will be demonstrated 
that the binding of various lipophilic pharmaca m the chylomicrons and 
other lipoproteins is much greater after oral administration than during 
in vitro incubation with these lymph constituents Hence, it may be 
concluded that although lipid solubility plays a major role, there may 
be something beyond lipid solubility determining the incorporation of 
the pharmacon into the chylomicron and, as a result, influencing 
lymphatic transport This is consistent with the report of Cohn and 
Sieber (1970) regarding the transport of DDT m the rat 
CHAPTER 5 
BINDING OF VITAMIN D3. DDT, DIELDRIN, QUINESTROL AND 
MESTRANOL TO THORACIC DUCT LYMPH COMPONENTS 
UNDER VARIOUS CONDITIONS 
5.1. INTRODUCTION 
It has been well demonstrated that a number of pharmaca are absorbed 
to a considerable extent via the lymph tract after oral administration 
in fatty vehicles. These pharmaca all have a strongly lipophilic nature. 
The Δ Rm value with respect to butter yellow of these compounds 
appears to be always > 0.2 (see chapter 4). Strong binding to chylomi­
crons is known for a number of them. DDT, (Cohn and Sieber, 1970), 
cholesterol (Treadwell and Vahouny, 1968), vitamin A and β carotene 
(Huang and Goodman, 1965), vitamin D (Schachter et al, 1964), 
vitamin E(Blomstrand and Forsgren, 1968b) and vitamin K, (Blomstrand 
and Forsgren, 1968a) appear to be present in the chylomicrons for 
80-90 per cent of the quantity absorbed via lymph. The transport of 
these pharmaca in the chylomicrons may be based upon one or more 
of the following processes: 
1. A non-specific form of interaction between pharmacon and fat com­
ponents of the lymph like the chylomicrons, due to the marked lipophili-
city of the pharmacon. 
2. An interaction between the pharmacon and specific parts of the 
chylomicron. Namely in those chylomicrons consisting of a nucleus 
and a membrane. They consist of 80 per cent triglyceride, 11 per cent 
cholesterol (of which 80 per cent is esterified), 7 per cent phospholipids 
and 2 per cent proteins (see table 32) (Houtsmuller, 1969). The unstruc­
tured nucleus contains 99 per cent of the triglyceride, the esterified 
cholesterol and 30 per cent of the unesterified cholesterol (Zilversmit, 
1965; Huang and Kuksis, 1967). The structured membrane consists of 
a mosaic of the protein, 70 per cent of the unesterified cholesterol and 
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Table 32. Properties of lymph fractions**. 
composition in percents 
" c h ü H T d d e n 8 l t y Г а П 9 f l 0 t a t i O n e l e c t r o P h o r e s i s N terminal aminoacids (g/ml) (s») fraction triglyceride cholesterol phospholipid protein proteins 
chylomicrons 0.95 400 80 11 7 
VLDL 0.95— 20-400 pre β lipoprotein 55 13 22 
1.006 
LDL 1.006— 0-20 β lipoprotein 12 45 22 
1.063 
HDL 1.063— — α lipoprotein 6 18 26 50 asp 
1.21 
proteins > 1.21 — serumproteins — — — 100 
* VLDL = "very low density lipoprotein". 
LDL = "low density lipoprotein". 
HDL = "high density lopoproteln". 
** Data obtained from Houtsmuller (1969). 
2 
10 
21 
major 
ser 
thr 
ser 
thr 
glu 
minor 
glu 
asp 
glu 
asp 
ser 
thr 
1 percent of the triglyceride in a directed monolayer of phospholipids 
(Fraser et al, 1968; Lossow et al, 1969; Salpeter and Zilversmit, 1968). 
In spite of the fact that the chylomicron membrane is a monolayer, 
there remains a certain resemblance to the unit - membrane of 
Robertson (1957), which gives the best indication of the universal 
structure of all biological membranes up to now. The chylomicron shell, 
as well as the unit-membrane, contains a directed layer of lipids. The 
inner region of the unit-membrane is composed of a bimolecular layer 
of lipid molecules, particularly phospholipids and cholesterol. 
Much work has been carried out on the binding of pharmaca to bio-
logical membranes. The idea is, that specific ability for binding to 
certain membranes might be the basis for the specificity observed in 
many of the biological actions of a number of pharmaca. Investigations 
according to this idea are reported for vitamin A, E and K, (Lucy and 
Dingle, 1964), vitamin D (Spirichev and Blazeheevich, 1968), steroids 
like stilbestrol and progesterone (Weissmann and Keiser, 1965), DDT 
(Tinsley et al, 1971), 3-methylcholanthrene (Weiner et al, 1971) and 
A l-tetrahydrocannabinol (Chari-Bitron, 1971). 
Based on the discussed analogy between the chylomicron shell and 
biological membranes, one might also expect a specific interaction 
between the discussed pharmaca and the chylomicron shell. 
3. Interaction between certain pharmaca and chylomicrons could be 
related to the process of chylomicron formation in the mucosa cells. 
One may imagine two possible processes: a. The pharmaca could be 
built into the chylomicrons by an active process, b. During the process 
of chylomicron formation, the pharmaca and the fat components of the 
chylomicrons are present in the mucosa cells in relatively high con-
centrations. The pharmaca could interact with fat components and 
together they could complete the formation of the chylomicrons. In this 
way the pharmaca may be captured within the shell of the chylomi-
crons. In respect of this the question arises as to whether the route of 
administration, e.g. oral or parenteral, plays a role in the degree of 
lymphatic transport. 
As has been mentioned previously in this introduction, cholesterol, fat 
soluble vitamins and DDT are not bound to chylomicrons for 100 per 
cent, but only for 80-90 per cent. In relation to this it is of importance 
that recent investigations have shown that mucosa cells not only form 
chylomicrons but also other lipoproteins such as very low density 
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lipoproteins (VLDL) (Ockner et al, 1969), low density lipoproteins 
(LDL) and high density lipoproteins (HDL) (Roheim et al, 1966; 
Dietschy and Siperstein, 1965; Windmueller and Spaeth, 1972). It is 
also known that these lipoproteins and other proteins are present in 
mesenteric lymph in considerable amounts (Yoffey and Courtice, 1970). 
The question now arises, as to whether the latter mentioned lipoproteins 
and the proteins, are responsible for binding the 10-20 per cent of 
cholesterol etc. that is not bound by the chylomicrons. 
We have tried to answer these questions by the following experiments: 
Five pharmaca were investigated: vitamin D3, DDT, dieldrin, quinestrol 
and mestranol. These pharmaca are different in respect to their 
lymphatic transport after oral administration. The amount of lymphatic 
transport may be classified as: a. considerable for vitamin D3 and 
DDT; b. moderate for dieldrin and quinestrol; с practically no transport 
for mestranol (see table 33). 
Table 33. Classification of some pharmaca in relation to their lymphatic 
transport after oral administration. 
pharmacon 
DDT 
vitamin D3 
dieldrin 
quinestrol 
mestranol 
Δ Rm value in respect lymphatic transport* 
of butter yellow in % 
0 38 (s.d. 0.01) 
1 23 (s.d. 0.12) 
0 24 (s.d. 0.01) 
0.24 (s.d. 0.03) 
-0.08 (s.d. 0.06) 
50.2 
75-100 
12.0 
18.3 
1.6 
category 
considerable 
moderate 
low 
* The amount of pharmacon, transported via the thoracic duct for 24 hr following 
administration is given as percentage of the apparent absorption. The average amounts 
of 3-8 experiments are given. Data about the lymphatic transport of vitamin D3 were 
obtained from literature (see chapter 4). 
Binding of these pharmaca to lymph components was obtained in 
three ways: 
- Lymph, obtained after fat administration (i.e. control lymph) was 
incubated in vitro with the pharmaca. 
- The pharmacon, in a fatty dosage form, was administered into the 
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stomach of the rat and after this thoracic duct lymph was sampled. 
- The pharmaca were injected intravenously into the tail of the rat 
and after this, thoracic duct lymph was sampled. Two hours before 
the injection, triolein was administered into the stomach of the rat 
so that at the moment of the injection a considerable amount of 
chylomicrons and other lipoproteins were present in the thoracic 
duct lymph. 
The amounts of pharmacon that were bound to chylomicrons, VLDL, 
LDL together with HDL and to the other proteins were investigated. 
The amounts of these pharmaca that were bound to chylomicron core 
and shell were also studied. 
5.2. EXPERIMENTAL PROCEDURES 
5.2.1. In vivo and in vitro experiments. 
The binding of the five pharmaca to the lymph fractions was accom­
plished in three ways. 
A. In vitro incubation of control lymph with the pharmaca. The rats 
were cannulated and treated according to the first type of animal ex­
periments (see chapter 2). Lymph was collected after repeated admini­
stration of 0.3 ml triolein. 8 ml portions of this lymph were incubated in 
duplicate with the different pharmaca. The pharmacon (see table 34) 
was added to the lymph, dissolved in 0.1 ml ethanol. The incubation 
was carried out at 37 0 C for 8 hr under continuous shaking (Bell and 
Schwartz, 1971). 
Table 34. Concentration and activity of the investigated pharmaca in 
thoracic duct lymph. 
radioactive pharmaca specific activity In цСі/тд amount In μς per 8 ml lymph 
14C-DDT 2.5 50 
"C-vltamln D3 83.0 1 
14C-dleldrln 2.5 50 
3H-quinestrol 500.0 1 
"C-meatranol 82.5 1 
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B. Administration of the pharmaca into the stomach. 
Rats were cannulated and treated according to the first type of animal 
experiments. The thoracic duct lymph was collected from 2 hr until 
8 hr after administration of the pharmaca into 0.3 ml triolein. Portions 
of 8 ml of this lymph were investigated. The quantity of the pharmacon 
administered to the rat was chosen such that the quantities of pharma­
con mentioned in table 34 were again present in the lymph samples. 
C. Administration of the pharmaca in the tail vein. 
The animal experiment carried out was also of the first type. іУг hr 
before the injection of the pharmacon into the rats 0.3 ml triolein was 
administered via the stomach cannula. At the moment of injection of 
the pharmacon there was a considerable amount of lipoproteins present 
in the lymph. The pharmacon, dissolved in 150 mg propylene glycol, 
was injected into the tail vein. The thoracic duct lymph was collected 
for 6 hr following the injection. Lymph portions of 8 ml were analyzed. 
The quantity of pharmacon in these lymphs was the same as described 
in table 34. 
5.2.2. Analytical procedures. 
By ultracentrifugation the lymph was divided into 4 fractions: chylomi­
crons, VLDL, LDL-HDL and other proteins. A preliminary test of these 
fractions was carried out on control lymph by subjecting the lymph 
fractions to electrophoresis. It was determined previously, by means 
of dialysis, that the pharmaca were bound to the fractions for more 
than 99 per cent. The content of chylomicrons and VLDL in these frac­
tions was determined by estimating the amounts of triglyceride in these 
fractions; the fractions LDL-HDL and other proteins were determined 
by estimating the protein content. It was assumed that the lipoprotein 
composition was as is reported by Houtsmuller (1969) (table 32). By 
means of the amounts of triglyceride and proteins determined, the 
percentage of lipoprotein could be calculated. The protein content of 
the fraction LDL-HDL was supposed to be 35.5 per cent of total weight. 
The amount of pharmacon in the lymph fractions was measured by 
counting the radioactivity in a liquid scintillation counter according to 
the method described in chapter 2. 
The chylomicrons were separated further into core and membrane. The 
oil layer of the cores which developed was separated from the mem­
branes by centrifugation. The amount of pharmacon in the core and 
the membrane was measured by counting the radioactivity. All lymph 
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samples and lymph fractions were stored at 4 0 C and analyzed within 
3 days. 
5.2.2.1. Dialysis. 
Dialysis was carried out in Visking, seamless cellulose tubing of 8/32". 
Duplicates of radioactive DDT, mestranol, dieldrin, vitamin D3 and 
quinestrol in quantities of a few micrograms were added to portions 
of 1 ml control lymph. This was dialysed against physiological saline 
for 17 hr at 20 0 C. DDT, dieldrin, vitamin D3 and quinestrol appeared 
to be bound to the lymph fractions for > 99.9 per cent, whilst mestranol 
was bound for 99.0 per cent. 
5.2.2.2. Separation of lymph in fractions by means of ultracentrifuga-
tion. 
The blood cells were always separated from the lymph beforehand by 
centrifuging for 10 min at 2000 RPM. In each experiment this cell-free 
lymph was separated into 4 fractions. The course of the fractionation 
was as follows: 
A. Chylomicron fraction. 
This was obtained by placing a liquid column of 0.85 per cent NaCI 
solution (Lascelles and Wadsworth, 1971) above the lymph sample. 
After centrifugation for 1 hr at 5 0 C in a M.S.E. Refrigerator Centrifuge 
at 20,000 g the chylomicron fraction could be removed with a pasteur 
pipette. 
B. VLDL fraction. 
This fraction was obtained by centrifuging the remaining lymph for 
18 hr at 120,000 g in an Omega II Christ Ultracentrifuge (Viikari, 1969). 
Then the fraction was removed with a pasteur pipette. 
С LDL-HDL 
The remaining liquid was brought to a specific density of 1.21 with a 
concentrated solution of saline. It was then centrifuged for 18 hr at 
120,000 g. The LDL-HDL fraction was removed with a pasteur pipette. 
(Havel et al, 1955). 
D. Protein fraction. 
This remained on the bottom of the centrifuge tube after the process 
described under С 
5.2.2.3. Purity test of lymph fractions. 
The purity of the lymph fractions was tested by electrophoretic 
procedures. 
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Electrophoresis of control lymph on cellulose acetate gave electro-
pherograms after fat and protein staining as illustrated in fig. 46 
(Sargent, 1969; Jansen, 1971). The electrophoresis was carried out on 
cellulose acetate strips of 160x25 mm (Schleicher und Schuil) using 
the "Elphor" apparatus (Bender and Hobein). The procedure was car­
ried out according to Perl and Voggel (1969). The samples were placed 
on the strips with a special applicator (Jansen, 1971). This was made 
of V2H steel, length 2 cm, width 0.5 mm, thread distance 100 μ. 
I 1. chylomicrons 
I | Γ ! \ ! 2. β lipoprotein 
! | |; ! ¡ ! | fat 3. pre β lipoprotein 
'—* '—
L
—'-—•—'—'• 4. a-llpoprotein 
5. — 
1 2 3 4 5 5. albumin 
Fig. 46 
Electropherogram obtained after fat and protein staining. 
After the developed electropherograms had been stained for protein 
with amido black 10 В or for fat with Schiffs reagent they were dried 
by means of a cold air current and made transparant with liquid 
paraffin. With the "Elphor-lntegraph" an extinction curve was con­
structed for these electropherograms. A planimeter was used to cal­
culate the relative percentages of lipoproteins and other proteins from 
these curves. This method was tested with a solution of albumin (Poviet) 
and globulin (Cohn fraction II from Koch-Light) in quantities approxima­
ting to those found in thoracic duct lymph (Yoffey and Courtice, 1970), 
namely 1000 mg albumin and 250 mg globulin in 25 ml physiological 
saline. 
Control lymph was separated into the 4 fractions by ultracentrifugation 
in the manner described. Electropherograms were made from the 
obtained fractions. By means of the procedures described the extent 
of separation of the lymph fractions was tested. It appeared that the 
electropherograms of each separated fraction corresponded fairly well 
with the expected electrophoretic pattern, although contaminations 
from other fractions were observed (1-5 per cent). 
5.2.2.4. Triglyceride determination. 
The triglyceride content of the chylomicron and the VLDL fraction 
was determined according to the method of Eggstein and Kreutz (1966), 
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using a Biochemica Test Combination from Boehringer. The procedure 
is based on an enzymatic determination of glycerol which was obtained 
by saponification of the fat in a sample. With a spectrophotometer 
(Carl Zeiss M4Q III with photomultiplier PMQ II) the course of the 
enzymatic reaction could be followed at 340 nm. 
5.2.2.5. Protein determination. 
This was carried out with the Folin phenol reagent according to Oliver 
(1951) as used by Faulkner and King (1970) for protein determination 
in blood serum. 
5.2.2.6. Separation of chylomicrons into core and shell. 
This was carried out according to the procedure of Zilversmit (1965). 
The chylomicron fractions were kept at - 40 0 C for 12 hr. Then the 
fractions were warmed for Уг hr to + 40 0 C. This process was repeated 
5 times. In this way a separation was achieved between nuclear material 
and outer shell material. The fractions could be separated by cen-
trifugation. The composition of both fractions has already been 
described in the introduction. The mass of the membrane material 
appeared to average 7.5 per cent of the chylomicron (Zilversmit, 1965; 
Huang and Kuksis, 1967). 
5.3. RESULTS AND DISCUSSION 
Since from the dialysis experiments it appears that the investigated 
pharmaca are bound to the lymph fractions for more than 99 per cent, 
it can be assumed that the lymph fractions that are obtained after 
separation by centrifugation, indeed contain the pharmaca in a bound 
state. 
The extent of binding of the pharmaca to the lymph fractions and the 
quantity of these fractions is shown in table 35 A. It is immediately 
apparent that the greatest percentage of the pharmacon is practically 
always bound to the chylomicron fraction, both when the pharmacon 
binding to the lymph fractions is obtained via oral or i.v. administration, 
or when the pharmacon was incubated in vitro with control lymph. 
The chylomicron fraction is usually present in the greatest quantity, 
whereas the protein fraction is also present in relatively great quan­
tities. The specific binding capacity of this fraction is relatively small. 
Table 35 В shows this more clearly. This table was derived from table 
35 A by calculation. The binding percentages of the pharmaca were 
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divided by the number of mg of the fraction and the figures obtained 
were converted to ratios, relative to the protein fraction taken as unity. 
The binding of the pharmaca to the chylomicron fractions, independent 
of how the binding of the pharmaca to the lymph fractions has been 
brought about, usually appears to be relatively larger than the binding 
to the protein fraction. Vitamin Da following i.v. administration is an 
exception. This is a special case and will be subsequently discussed. 
The fact that also following incubation and i.v. administration the 
binding of the pharmaca to the chylomicrons is so great, seems to 
confirm the impression that the degree of lipophilicity is primarily 
responsible for the binding of the pharmaca to the chylomicrons and 
that specific interactions capable of occurring in the mucosa cells, 
especially following oral administration, are only of secondary im­
portance. It has to be taken into account here that the results found 
are obtained by radioactivity measurements without correcting for the 
radioactivity of metabolites formed. An impression of the extent to 
which unmetabolized pharmacon can be present is given in table 36. 
This table was constructed from data from chapter 4. 3-4 hr following 
oral administration and г-І hr following i.v. administration of the 
pharmacon the percentage of unmetabolized pharmacon in mesenteric 
lymph and portal blood was determined. 
Conversion of the pharmaca after in vitro incubation with these lymphs 
was found to be smaller than in the lymphs obtained following oral 
and i.v. administration. The percentage of metabolites usually appeared 
to be relatively small in comparison with e.g. the binding ratio between 
chylomicron and lipoprotein fractions, so that in general the unmeasu­
red metabolites have little influence on the conclusions. 
It appears from table 35 A that the amounts of the VLDL and LDL-HDL 
fractions are often considerably smaller than those of the chylomicron 
and protein fractions. The question, posed in the introduction as to the 
state of the 10-20 per cent of cholesterol, fat soluble vitamins and DDT 
in the lymph, that was not found in the chylomicron fraction after oral 
administration, can also be answered from table 35 A. Attention must 
be paid to the results following b, oral administration. Except for 
vitamin D3, the greater part appears to be bound to the VLDL and 
LDL-HDL fractions. For vitamin D3 and also for mestranol a large part 
appears to be bound to the protein fraction. Table 35 В shows that the 
binding ratios e.g. in respect of the VLDL fraction are still 6 and 11 for 
respectively vitamin D3 and mestranol. A marked binding to the protein 
fraction could also be explained by the data from table 36. The metabo-
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Table 35 A Binding of DDT, vitamin Оз, dieldrm, qumestrol and mestranol to 
pharmacon 
DDT 
vitamin D, 
dleldrln 
qumestrol 
mestranol 
a 
b 
с 
a 
b 
с 
a 
b 
с 
a 
b 
с 
a 
b 
с 
binding 
to the lymph 
fractions 
following*** 
Incubation 
oral administration 
ι ν administration 
Incubation 
oral administration 
ι ν administration 
Incubation 
oral administration 
I ν administration 
Incubation 
oral administration 
I ν administration 
incubation 
oral administration 
I ν administration 
chyl 
binding* 
of pharm 
(%) 
87 1 
845 
96 4 
96 4 
72 0 
70 0 
87 2 
85 5 
85 5 
8 0 
6 0 
87 9 
85 6 
97 2 
96 8 
95 0 
95 0 
72 0 
83 8 
72 1 
741 
55 0 
56 0 
93 0 
303 
342 
55 0 
540 
omicrons 
amount** 
of chylomlcr 
(mg) 
45 
204 
77 
100 
113 
76 
45 
200 
76 
45 
47 
53 
107 
25 
75 
\ 
binding 
of pharm 
(%) 
9 3 
100 
1 6 
1 4 
8 0 
8 0 
3 3 
10 
1 0 
1 0 
8 0 
9 4 
1 7 
1 7 
3 0 
3 0 
91 
8 5 
71 
75 
140 
140 
2 0 
188 
21 8 
5 0 
5 0 
(LDL 
amount** 
of VLDL 
(mg) 
12 
0 6 
3 0 
55 
0 6 
1 6 
12 
14 
3 0 
12 
1 5 
22 
5 5 
31 
28 
100 
lymph fractions 
LDL-HDL 
binding 
of pharm 
(%) 
26 
43 
1 5 
1 4 
90 
100 
1 0 
24 
30 
150 
11 0 
27 
33 
08 
1 0 
1 0 
1 0 
100 
22 
150 
135 
amount** 
of LDL-HDL 
(mg) 
17 
41 
1 2 
04 
70 
20 
17 
15 
16 
17 
1 2 
protein fraction 
binding 
of pharm 
(%) 
10 
1 2 
05 
05 
11 0 
120 
85 
11 1 
105 
77 0 
82 0 
14 
1 7 
03 
05 
1 0 
10 
89 
55 
58 
49 
amount** 
of protein 
fraction (mg) 
30 
118 
33 
26 
33 
33 
30 
114 
42 
30 
60 
140 
140 
22 170 
160 
22 
30 
175 
158 
100 
80 
1 8 
21 
41 
20 
33 4 
28 9 
30 0 
33 0 
34 
52 
42 
The pharmaca binding to the 
lymph fractions is given as 
the radioactivity in the lymph 
fraction divided by the radio-
activity In the total lymph 
sample (In per cents) 
The amounts of chylomicrons. 
VLDL, LDL-HDL and the pro-
tein fraction (In mg) derived 
from 8 ml lymph 
The lymphs were obtained in 
3 ways, namely after Incuba-
tion of the pharmaca with 
thoracic duct lymph, accumu-
lated after administration of 
triolein and after oral and in-
traveous administration of the 
pharmaca and accumulation 
of the thoracic duct lymph 
2 hours before administra-
tion of the pharmacon, dissol-
ved In 0 1 ml propylene glycol, 
into the tail vein, 0 3 ml of 
triolein was administered oral-
ly to these rats The oral ad-
ministration was carried out 
with the pharmacon dissolved 
In 0 3 ml triolein 
101 
Table 35 В. Binding ratios of the pharmaca between the lymph fractions 
per unit of mass*. 
pharmacon 
DDT 
vi t D3 
dieldrin 
quinestrol 
mestranol 
, 
a. 
b. 
с 
a. 
b. 
с 
a. 
b. 
с 
a. 
b. 
с 
a. 
b. 
с 
binding to 
trie lympn 
fraction by 
Incubation 
ora 
l.v. 
admin. 
admin. 
chylomicrons 
57 
125 
3 
3 
3 
1/24 
38 
140 
50 
7 
16 
1 
15 
2 
1 
binding ratio 
VLDL 
24 
625 
8 
2 
6 
% 
15 
350 
40 
3 
55 
8 
7 
11 
2 
per unit mass 
LDL-HDL protein fraction 
6 1 
87 1 
24 1 
8 1 
1 1 
3 1 
4 1 
28 1 
25 1 
2 1 
130 1 
8 1 
30 1 
13 1 
2 1 
* The figures were obtained by dividing the binding percentages from table 35 A by the 
mass of the fraction (mg) and then rounded off as ratios taking the protein fraction 
as unity. 
lites formed (for mestranol approx. 30 per cent of the radioactivity 
measured in the lymph) are usually less lipophilic, and because of that 
a larger protein binding might be expected. The percentage of protein 
binding found would, in that case, not be due to unmetabolized vitamin 
D3 and mestranol. Moreover, the lipophilicity of mestranol is so low, 
that based only on a small lymphatic transport therefore, a different 
binding form must be expected (see chapter 4). 
It is of general importance to observe that the considerably lipophilic 
pharmaca are bound to the lipoproteins to a much greater extent than 
to the protein fraction. This is particularly obvious in table 35 В from 
the ratios per unit mass. Following oral administration there is, vitamin 
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Dj excepted, a rough analogy to be seen between lipoprotein binding, 
in respect of protein binding, and lipophilicity. One can also see in 
table 35 В that except for vitamin Da and for mestranol - the latter 
product is considerably metabolized following oral and i.v. admini­
stration (see table 36) - the binding ratio to the chylomicron fraction 
obtained in lymph following oral administration, is greater than that 
obtained following incubation or i.v. administration. 
This is even more obvious for the binding ratio of the VLDL fraction. 
It looks as though there is a special mechanism operative following 
oral administration through which these pharmaca are more strongly 
bound to the chylomicrons and the other lipoproteins. As has already 
been mentioned in the introduction, we can assume that the VLDL and 
Table 36. The presence of unmetabolized pharmacon in mesenteric 
lymph and portal blood at 3-4 hours after oral administration and at 
Уг-І hour after i.v. administration. 
percentage of unmetabolized pharmacon 
mode of administration ' n pharmacon 
DDT 
vitamin D3 
dleldrin 
qulnestrol 
mestranol 
Ρ·ο.' 
po. 
i.v. 
p.o. 
I.v. 
p.o. 
i.v. 
p.o. 
i.v. 
lymph 
97 
97 
80 
90 
86 
92 
98 
96 
93 
83 
81 
70 
73 
64 
portal blood 
72 
72 
83 
27 
57 
85 
85 
51 
43 
43 
45 
14 
26 
37 
The oral administration of the pharmaca was carried out In 0.3 ml triolein. This ex­
periment was always conducted on 2 rats. 
2 Hours before the administration of the pharmaca, dissolved in 0.1 ml propylene 
glycol, into the tail vein, 0.3 ml of triolein was orally administered to the rats. This 
experiment was always conducted on I rat. 
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the LDL-HDL fractions can also be formed in the mucosa cells. As far 
as the chylomicrons are concerned we see in table 38, that a greater 
relative binding ratio of the pharmaca occurs in the nucleus, analogous 
to the mentioned phenomenon following oral administration. In the 
lymph samples, obtained after incubation and i.v. administration, the 
shell of the chylomicron binds relatively more pharmacon than following 
oral administration, whereas these binding ratios per unit mass are 
even absolutely greater following the first mentioned mode of admini-
stration. It looks as if, following incubation and i.v. administration, the 
pharmacon binds itself to a larger extent to the shell, due to apposition 
with the outside of the completed chvlomicron, whereas the pharmacon 
has access to the nucleus to a higher extent following oral admini-
stration. Without being able to decide from these experiments which 
interaction form between chylomicron and pharmacon plays a role 
following oral administration, besides the one based on lipophilicity, 
we conclude that this special interaction form, e.g the form mentioned 
in the introduction under 3b, in which it is assumed, that the pharmacon 
is caught within the shell of the chylomicron during the process of 
chylomicron formation, could be possible. Since the shell of the VLDL 
and the LDL-HDL particles contain considerably more constituents than 
the shell of the chylomicrons, this might explain the relatively greater 
binding with these lipoproteins following oral administration. 
Dicumarol has little lipophilicity (see chapter 4) and a marked protein 
binding. It is practically insoluble in water. Table 37 shows that it is 
bound to the protein fraction to a considerable degree Table 38 shows 
that is binds particularly to the shell of the chylomicron following oral 
administration This shell contains among other things protein, so that 
the chylomicron can possibly generate binding of dicumarol via this 
Table 37. Binding* of dicumarol to the lymph fractions following oral 
administration. 
chylomicrons VLDL LDL-HDL protein fraction 
DPM per cent DPM per cent DPM per cent DPM per cent 
4191 39 2600 24 1062 10 2859 27 
* The binding of "C-dicumarol is mentioned as percentage of the found radioactivity 
m the lymph fraction, divided by the total quantity of radioactivity in the lymph sample 
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Table 38 Binding ratio of the pharmaca between shell and nucleus of 
the chylomicrons per unit mass shell and nucleus*. 
binding to the lymph binding ratio per unit mass** pharmacon 
DDT 
vitamin D3 
dieldrm 
qumestrol 
mestranol 
dicumarol 
a. 
b 
с 
a 
b 
с 
a 
b 
с 
a 
b 
с 
a 
b 
с 
b 
fraction followir 
incubation 
oral admin 
ι ν admin 
shell 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
nucleus 
7 
16 
7 
4 
10 
9 
6 
18 
15 
2 
5 
4 
6 
17 
8 
2 
The determinations were conducted using a sample of the chylomicrons obtained 
by the experiments mentioned in table 35 A 
In the determination of this ratio the mass ratio between shell and nucleus 
7 , / 2 % ЭЗ'/гУо = 1-12 was taken into account. 
5.4 CONCLUSION 
The results of the experiments carried out agree with the concept that 
the interaction between strongly lipophilic pharmaca, such as DDT, and 
chylomicrons, primarily comes about as a function of the great 
lipophihcity of DDT. Besides that, there is possibly another form of 
interaction occurring following oral administration through which 
relatively more pharmacon appears in the nucleus of the chylomicron. 
It is difficult to decide from these experiments that a specific binding 
to the chylomicron shell, as discussed in the introduction, occurs. This 
is also true for vitamin Da, which shows in table 35 В abnormal binding 
ratios as compared with DDT and dieldrm. The binding of vitamin Da 
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to the protein fraction is relatively much greater than of the other phar-
maca. Following i.v. administration this binding is even more pronoun-
ced with the protein fraction. Something special is occurring here, the 
explanation for which we may find in recent publications. Various 
investigators have found that vitamin D3 in serum is, for the greater 
part, bound to proteins and not, or nearly not, to lipoproteins. Rikkers 
and DeLuca (1967) made observations at regular time intervals 
following oral and i.v. administration of vitamin D3. Their observations 
suggest that the vitamin is transported to the liver by lipoproteins 
following administration. There a specific event occurs which results 
in the formation of a complex of the vitamin with a non-lipoprotein frac-
tion, which then appears in the serum. Peterson (1971) described the 
isolation and characterization of a specific vitamin D-binding plasma 
protein. The results found by us can be explained in terms of these 
findings. As already mentioned above, dicumarol appears to be bound 
to a great extent to the protein fraction. In chapter 4 one can see that 
dicumarol, after oral administration, shows a concentration quotient of 
approx. 1 in lymph with respect to portal blood. So this pharmacon 
does not show a specific larger absorption via the lymph tract. Ap-
parently strong binding to protein is not specifically responsible for 
great lymphatic transport, as opposed to the marked binding of for 
instance DDT to lipoproteins. 
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CHAPTER 6 
INFLUENCE OF FATTY AND NON-FATTY DOSAGE FORM ON 
DISTRIBUTION AND METABOLISM OF DDT 
AND ALDRIN IN THE RAT 
6.1. INTRODUCTION 
When DDT is administered orally to the rat in micellar solution, about 
50 per cent of the amount absorbed is transported in the lymph tract. 
On the other hand, when DDT is given in a non-fatty solution (propylene 
glycol) only about 14 per cent is transported in the lymph tract (see 
chapter 3). Also aldrin is absorbed in a greater amount via the lymph 
tract (about 33 per cent of the apparent absorption, see chapter 4) 
when given in triolein than when given in propylene glycol (about 10) 
per cent). It is believed that the absorption from the gut occurs via the 
lymph tract and the portal system (see 3.3.1.). So, if a great part of the 
absorbed DDT or aldrin is transported via the lymphatics, a small part 
has gone via the portal system. What are the consequences of absorp-
tion via the one or the other route as to the distribution and metabolism 
of DDT and aldrin? 
Theoretically, if the pharmacon is absorbed exclusively via the portal 
system, then it goes directly to the liver (see fig. 47). The liver has a 
great capacity for metabolizing, eventually inactivating, a pharmacon. 
For instance, some steroids like testosterone and nandrolone can only 
be therapeutically effective when given as an injection, so that an 
initial passage through the liver is avoided (Biskind and Mark, 1939; 
Biskind, 1940; Kupperman, 1965). 
If, on the other hand, the pharmacon is absorbed exclusively via the 
lymph tracts of the gut (the chyle vessels) then it will come into the 
blood via the vena subclavia and then it is possible that the pharmacon 
reaches its sites of action or that it is captured in certain tissues like 
the fat depots for instance, without passing the liver. The blood flow in 
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the splanchnic area of man in rest is about 1800 ml/min and his heart 
minute volume about 5250 ml (Rein und Schneider, 1960). This means 
that during one circulation of blood through the body about 1/3 passes 
the liver (see fig. 47). If a pharmacon, transported exclusively via the 
lymph tract into the blood of the vena subclavia, does not leave the 
vascular system, then it can be calculated that, after 6 circulations 
through the body, about 9 per cent of the pharmacon still has not 
passed the liver. 
Fig 47 
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If an orally given pharmacon is absorbed exclusively via the lymphatic 
system (and is not changed during absorption) then it will be transpor-
ted in the vascular system much the same as if it was administered 
parenterally. 
6.1.1. Role of the chylomicrons in drug distribution. 
The greater amount of the drug absorbed via the lymph tract compared 
to the portal system is not the only factor that could influence the 
pattern of distribution and metabolism of this drug. The fact that the 
lymphatic transport of pharmaca appears to be coupled to fat transport 
may also be of importance. In this respect the chylomicrons play a role, 
and to a much smaller degree so do the other lymph components, such 
as the lipoproteins and the proteins (see chapter 5). 
If we suppose that the pharmaca remain present ¡n the lymph com-
ponents when these merge from the thoracic duct into the blood of the 
vena subclavia and after that are transported with this blood in the 
vascular system, then the distribution of these pharmaca will be par-
ticularly coupled to the fate of the chylomicrons. Some characteristic 
facts are now known about the distribution (and the metabolism) of the 
various fat components of the chylomicrons in the body. 
If a pharmacon, present in the chylomicrons, shows affinity for one 
or more fat components present there, and follows these fat com-
ponents in their distribution through the body, then the distribution of 
this pharmacon would be predictable based on our knowledge of the 
distribution of these fat components. 
Chylomicrons are structured (see 5.1.). In the nucleus there are 
triglyceride and cholesterol esters. This nucleus is surrounded by a 
stabilizing membrane which is composed of a mosaic of protein, 
cholesterol and triglyceride (1 per cent) in a directed monolayer of 
phospholipids. The chylomicrons disappear out of the blood very 
rapidly. It is generally accepted, that during the first step of chylomi-
cron metabolism about 80 per cent of triglyceride is removed by 
lipolysis. This action is mediated by lipoprotein lipase in the peripheral 
tissues, especially adipose tissues (Redgrave, 1970; Olivecrona and 
Fex, 1970; Bragdon and Gordon, 1958). 
The apparent half life of chylomicron - triglyceride appeared to be 
2.8 ± 0.37 (s.d.) min in unanesthetized rats (Harris and Felts, 1970). 
After lipolysis the residue of the chylomicron appears in the plasma 
as a high density lipoprotein, which is subsequently metabolized mainly 
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by the liver. So for instance cholesterol, a normal constituent of the 
chylomicrons, is found both esterified and free. It was reported by 
Olivecrona and Fex (1970), that this compound goes mainly to the liver. 
Vitamin D3, which has an analogous sterol structure, is found to behave 
similarly to cholesterol in this respect. It was shown by Norman and 
DeLuca (1963), that 3H-vitamin D3 after oral administration to the rat 
is transported for the greater part via the lymphatics and rapidly 
accumulates in the liver. This demonstrates the general principle that 
the liver is avoided when a pharmacon is not absorbed via the portal 
system but via the lymphatics, does not hold true if the pharmacon is 
transported, like cholesterol, in the residual chylomicron after lipolysis. 
In that case a specific transport to the liver occurs. 
6.1.2. Set-up of the present experiments. 
For investigating the influence of fatty or non-fatty dosage form on the 
distribution and metabolism of a pharmacon that is absorbed in a con-
siderable amount via the lymph tract, DDT and aldrin were chosen as 
examples. 
6.1.2.1. DDT. 
The choice of DDT in this study was advantageous, because much in-
formation about the lymphatic absorption of DDT has been gathered 
by us (see chapter 3, 4 and 5). For instance, it was found that DDT is 
captured fora great amount in the fat tissue of the body. 
An impression of distribution and metabolism was obtained in the 
following ways: A. Distribution of DDT and its metabolites between fat 
tissues and liver in relation to fatty or non-fatty dosage form. 
When DDT is absorbed via the portal system one could expect a dif-
ferent ratio of the amounts of DDT and its metabolites in liver and 
perirenal fat tissue than when DDT is absorbed via the lymph tract (see 
fig. 47). In order to check this, ,4C-DDT in fatty micellar solution or in 
non-fatty propylene glycol, was administered in the stomachs of rats. 
Several hours after administration a sample of perirenal fat and the 
liver were taken surgically, and 14C radioactivity per g of tissue was 
determined. The quotients of radioactivity in 1 g fat / 1 g liver were 
calculated for each rat. These quotients, representing the distribution 
of radioactivity to fat and liver, were plotted as a function of time. 
B. Ratio between DDT and metabolites in perirenal fat in relation to 
fatty or non-fatty dosage form. 
DDT in primarily metabolized to DDD (see fig. 48) in the liver of man 
and rat (Morgan et al, 1971; Peterson and Robison, 1964). Thereafter 
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DDD is metabolized via various intermediates to DDA DDA is soluble 
in water. DDT and DDD are both found m fat tissue. DDT is metaboli-
zed poorly to DDE m man (Morgan and Clifford, 1971). This also holds 
true for the rat (Peterson and Robison, 1964) The metabolism of DDT 
to DDD occurs particularly in the liver In this respect, the intestinal 
flora of the rat only plays a minor role (Ottobom and Ferguson, 1968, 
Alary et al, 1971) Therefore, when the absorption and subsequently 
the transport of DDT to the liver and perirenal fat is different in relation 
to fatty or non-fatty dosage form, one could also expect a different ratio 
of DDT to DDD in perirenal fat m relation to the dosage forms In 
that DDT, that is transported primarily via the portal tract to the 
liver, can be metabolized m the liver to DDD Thereafter unmetabolized 
DDT and DDD is redistributed from the liver to, for instance, perirenal 
fat On the other hand, when DDT is transported primarily via the lymph 
tract, then it may be stored in fat tissues as unmetabolized DDT. In the 
present experiments the amounts of ,4C-DDT and its metabolites 
14C-DDD and 14C-DDE were determined in samples of perirenal fat, 
obtained 12 hr after administration m the stomach of ^C-DDT m 
micellar solution or in propylene glycol respectively. 
6 12 2 Aldrm 
Aldrm was chosen for these experiments for the following reasons 
The general view is, that aldrm is metabolized very rapidly to its 
epoxide dieldnn (see fig 49) This occurs nearly exclusively in the liver 
(Hunteret al, 1960; Wong and Temere, 1965). Aldrm as well as dieldnn 
α ci 
Cl CI 
ALDRIN DIELDRIN 
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have a great fat-solubility and are taken up in a considerable amount 
in the retroperitoneal fat tissue (Heath and Vandekar, 1964). With 
aldrin the same experiments were done as described above for DDT. 
6.2. EXPERIMENTAL PROCEDURES 
6.2.1. Animal experiments 
The rats were fasted 15-20 hr before the administration of the phar-
macon. During this time and also during the experiment the rats had 
free access to water. The pharmacon was administered to the rats 
with a cannula via the mouth into the stomach. 1 mg DDT containing 
1 μΟί ,4C-DDT, was administered on the one hand in 0.3 ml propylene 
glycol, on the other hand in 4 ml micellar solution. In the same way 
1 mg aldrin containing 1 μΟ 14C-aldrin was administered in 0.3 ml 
propylene glycol and in 0.3 ml triolein. Resp. at 1, 3, 6 and 12 hr 
after administration of the mentioned doses of DDT and aldrin, the 
rats were anesthetized with ether and samples of perirenal fat and 
the liver were taken. All samples were stored at - 18 0 C and analyzed 
within 3 days. 
6.2.2. Analytical procedures. 
Sampling, homogenizing and determination of the amount of radio­
activity in perirenal fat and liver samples was performed as mentioned 
previously (see 2.7.). 
6.2.2.1. Determination of DDT and aldrin and their respective metaboli­
tes in perirenal fat. 
Homogenization and extraction were performed as described in chapter 
2 (2.7.1.7. and 2.7.3.). After extraction, the obtained chloroform fraction 
was purified further with the aid of an aluminium oxide column accor­
ding to Holden and Marsden (1969). This purification procedure is as 
follows: The alumina powder used is analytical grade aluminium 
hydroxyde (Fluka) activated at 800 0 C for 4 hr, cooled in a desiccator, 
partially deactivated by shaking with 5 per cent by weight of distilled 
water for 30 min and stored in a closed vessel. The column is prepared 
by placing 2.0 ± 0.1 g of alumina powder in a 45 cm long χ 0.6 cm bore 
chromatographic tube having a glasswool plug at its lower end. For 
extracts containing up to 100 mg of extracted fat a single alumina 
column is sufficient for satisfactory clean up. The chloroform extract of 
the extraction of Bligh and Dyer is evaporated to dryness with N2 and 
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the rest taken up in 1.0 ml of hexane. This solution is placed on the 
alumina surface by means of a pipette. The solution is drained down 
one side of the glass column and washed into the alumina by refilling 
the pipette with 1 ml of hexane and draining down the same side of the 
column. A further 20 ml of hexane is added. After collecting the hexane 
fractions, the measuring flask is filled with hexane to 25 ml. The column 
was tested with ,4C-DDT and 14C-dieldrin and the activity remaining 
appeared to be less than 1 per cent. Duplicate 10 ml samples of the 
hexane solution were brought onto a precoated silica-gel G glass plate 
as described in 4.2.3. Standard markers of '"C-DDT, 14C-DDD and 
14C-DDE were also placed on the plate. Liquid η-heptane according 
to Kovacs (1963) was used as mobile phase. 
The Rf - values for DDT, DDD and DDE were found to be resp. 0.23, 
0.11 and 0.37. The Rf - values for aldrin and dieldrin were, respectively, 
0.44 and 0.11. The measurement of the radioactivity is described in the 
general procedures (2.7.4.3.). 
6.3. RESULTS 
6.3.1. Influence of the dosage form on fat/liver quotients of DDT and 
aldrin. 
As can be seen from fig. 50 the fat/liver quotient for DDT and aldrin 
increases with time. The absolute concentration of these compounds 
in the liver was found to be fairly constant. The concentration in perire­
nal fat increased during 12 hr after administration. It can also be seen 
in fig. 50A and B, that the fat/liver quotient for DDT and aldrin is in­
fluenced by the dosage form employed. As compared with the ad­
ministration of these compounds in propylene glycol, it appears that 
a fatty dosage form, probably by favouring the transport via the 
lymphatics, results in a relatively greater concentration in the fat tissues 
as compared with the liver (at 12 hr: for DDT and aldrin Ρ < 0.05; 
Student t-test). As mentioned already Norman and DeLuca (1963) 
found that vitamin D3, although transported via the lymphatics, accumu­
lates in the liver. This is not the case with DDT, which accumulates to 
a considerable extent in fat tissue. This might be explained on the basis 
of our findings in chapter 5, that DDT in a considerable amount is 
present in the core of the chylomicrons. The core consists of triglyce­
ride which is mainly removed by lipolysis in the fat tissues. So relatively 
high concentrations of DDT are reached there. 
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time (h ) 
Fig 50 A, В 
Fat/liver quotients for 14C-DDT and ,4C-aldrin at different times after oral administration 
in fatty and non-fatty dosage forms The values are based on amounts of total radio­
activity It has not been accounted for the presence of metabolites. The vertical bars 
refer to S Ε M for 6 animals 
6.3.2. Metabolites of DDT and aldrin in perirenal fat. 
DDT. 
In each experiment 2 samples of perirenal fat were taken at 12 hr after 
administration. In 1 sample total " C radioactivity per g was determined. 
In the other sample, DDT and its metabolites were separated and iden­
tified. Two metabolites were found, namely DDD and DDE. The sum of 
14C radioactivities of these 3 fractions appeared to be 97 per cent of 
the radioactivity measured in the former sample. Fig. 51 clearly demon­
strates that, depending on a fatty or non-fatty administration form, the 
ratio between DDT and its metabolites are different. DDT, when ad­
ministered in propylene glycol, is metabolized to a greater extent than 
114 
when it is administered in a micellar solution. This is understandable 
if we take into account the fact that DDT in propylene glycol is trans­
ported to a greater extent via the liver, the main site of metabolism. 
As mentioned already, the conversion of DDT into DDE by the rat is of 
minor importance (Peterson and Robison, 1964). In agreement with 
this the amount of DDE in the renal fat is only 3-4 per cent. 
Fig. 51 
Amounts of DDT, DDD and DDE 
in perirenal fat as percentages of 
total 14C radioactivity, measured 
at 12 hr after administration of 
DDT in non-fatty and fatty dosage 
forms. Means are given for 3 
separate experiments. 
Note: DDT is metabolized to a 
greater extent, when administered 
in propylene glycol. This corres­
ponds with a greater passage 
DDT DDD DDE DDT DDD DDE through the liver. 
Aldrin. 
From the literature it is known that aldrin is very rapidly converted to 
dieldrin in the rat. Therefore, in the case of aldrin administration in the 
different dosage forms, samples of perirenal fat were taken after 3 hr. 
Although the lymphatic transport of aldrin, given in triolein, is greater 
than when administered in propylene glycol, in absolute terms the 
amount of aldrin which is absorbed via the lymph, is only small com­
pared to DDT. This phenomenon, and in addition the fast metabolism 
of aldrin, may be the explanation for the smaller difference observed 
between aldrin and dieldrin in relation to the fatty and non-fatty dosage 
form (see fig. 52). 
6.4. CONCLUSION 
The finding that administration of DDT and aldrin in a fatty dosage 
form results in a relatively greater concentration of these compounds 
in the fat tissue, may justify the conclusion that the absorption route, 
which in its turn is dependent upon the dosage form, can influence 
the distribution pattern of highly lipophilic pharmaca in the organism. 
In this respect, if transport via the lymph tract occurs, the binding to 
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Amounts of aldnn and dieldnn in peri-
renal fat as percentages of total ,4C 
radioactivity, measured at 3 hr after 
administration of aldnn in non-fatty and 
fatty dosage forms Means are given for 
3 separate experiments 
lipoproteins, particularly the chylomicrons, might also be of importan-
ce. On this basis the different distribution pattern of DDT and vitamin 
D3 (Norman and DeLuca, 1963) between liver and fat tissue can be 
explained (see 6 3 1.). Moreover the different routes of absorption 
dependent on the different dosage forms, has, as a matter of fact, 
consequences for the biotransformation of lipophilic pharmaca. This is 
clearly demonstrated in fig. 51, where, if DDT is forced by the non-fatty 
dosage form to take the absorption route via the liver, then a substan-
tial amount of metabolites is found. However, in the case of transport 
via the lymphatics as a consequence of the fatty dosage form, prac-
tically no metabolites have been observed. It is generally assumed that 
DDT is metabohcally stable. This is probably due to the fact that 
DDT - since it is in most cases absorbed from the gut in combination 
with fatty components - does not reach the liver, rather than that this 
organ is unable to convert it. 
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CHAPTER 7 
SUMMARY 
In the present thesis investigations are described which were carried 
out in order to obtain more information about the role of the lymphatic 
system in the absorption of pharmaca from the gut The various studies 
concentrate particularly on the following questions, which are more 
extensively discussed in chapter 1: 
- Which drugs are absorbed to a great extent via the lymphatics and 
what are the properties that lead to such an absorption7 
- Is it possible to directly influence the absorption in the direction of 
the portal system or the lymphatics by means of the vehicle7 
- Are there pharmacologic consequences of influencing the route of 
absorption7 
Since the flow of mesenteric lymph is only 1/500 of the flow of the 
blood m the portal system, it is clear then that absorption of pharmaca 
via the lymphatics plays only a major role when a concentration of the 
pharmacon is reached in the lymph which is considerable compared to 
the blood concentration. A low degree of interchange of the drug 
between the blood and lymph, may be mentioned as another condition 
for selective lymphatic transport If a drug is absorbed from the gut via 
the portal system then it goes directly to the liver, which has a great 
capacity for metabolizing, and eventually for inactivating, such a com-
pound If, however, a drug is absorbed exclusively via the lymphatic 
tract of the gut, then this drug will be transported into the blood of the 
vena subclavia and may reach its site of action without passing through 
the liver This may of course have pharmacologic consequences 
Chapter 2 reports the materials used, the animal experiments and the 
analytical procedures Special attention was paid to the description of 
the techniques for lymphatic cannulations and the cannulation of portal 
vessels The latter procedure was developed m order to obtain samples 
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of portal blood continuously during several hours whithout anaestheti­
zing of the rats 
In chapter 3 are described the results which indicate that the dosage 
form can influence the route of absorption of a drug, either via the 
portal system or via the lymph tract 
The following dosage forms of DDT have been compared in this 
respect The non-fatty solvent propylene glycol and the fatty solvents 
triolein and a micellar mixture If DDT was administered in a non-fatty 
solvent such as propylene glycol, considerably less absorption via the 
lymphatics took place as compared to DDT administered in the fatty 
dosage forms However, DDT administered m propylene glycol was to 
a greater extent absorbed via the portal system So it is clear that DDT, 
which is highly lipoid soluble, is not only absorbed well from a fatty 
dosage form but also from a non-fatty solution, be it via an alternative 
route 
From experiments with bile cannulation it might be concluded that, 
with respect t o a selective transport via lymphatics, the micellar 
solution is preferable to the triolein solution in those cases in which 
bile f low is disturbed or absent 
In chapter 4 investigations are described concerning the lymphatic 
transport of 21 compounds including some insecticides, halogenated 
hydrocarbons, a carcinogen such as methylcholanthrene and other 
pharmaca On the basis of the results from chapter 3 it could be 
expected that lymphatic transport would be optimal when these com­
pounds were administered m a fatty dosage form The amount of the 
various substances (radioactively labelled) were collected m the 
thoracic duct lymph and measured at different intervals up to 24 hr 
after oral administration 
As to the question posed above regarding which properties of the com­
pounds lead to a considerable lymphatic absorption, it can be said that 
only those compounds with a high lipophilicity are absorbed selectively 
via the lymph tract This selective absorption can also be inferred from 
the great concentration of the compounds m the mesenteric lymph fluid 
compared with the concentration m the portal blood For the compounds 
under investigation the correlation between lymphatic transport and 
lipophilicity was studied As a measure of l ipophilicity Δ Rm m respect 
of butter yellow ( 4 2 5 ) was determined with the aid of reversed phase 
chromatography It appeared that there exists a linear correlation 
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(г = 0.850) between the log of the apparent lymphatic absorption and 
the Δ Rm value of the various compounds. 
Chapter 5 reports binding studies with vitamin D3, DDT, dieldrin, 
quinestrol and mestranol to lymph components under various con­
ditions. Thoracic duct lymph was collected and fractionated by means 
of ultracentrifugation into the following sub-fractions: chylomicrons, 
VLDL (very low density lipoproteins), LDL-HDL (low density lipopro­
teins and high density lipoproteins) and a fraction containing the other 
proteins. Three types of binding studies were performed. The phar-
macon was administered beforehand to the animal, either per os or 
intravenously and lymph was sampled and subsequently analyzed or, 
in the third type of experiments lymph was sampled and thereafter 
the pharmacon was added in vitro and the lymph was analyzed. 
The main result appeared to be that in most cases the investigated 
pharmaca were present for more than 80 per cent in the chylomicron 
and other lipoprotein fractions. Binding to other proteins played a 
minor role. It appeared that the binding per unit mass of the chylomi­
crons and other lipoproteins was substantially greater when the com­
pounds were administered orally as compared to the binding after in­
travenous or in vitro application. 
In further experiments chylomicrons were subdivided into a nucleus 
fraction and a shell fraction. The binding of the pharmaca to these 
fractions has also been studied. It transpired that, particularly after 
oral administration, the pharmaca enter into the nuclei of the chylomi­
crons. These results lead to the supposition that there might be a 
special mechanism operative following oral administration through 
which these pharmaca are more strongly bound to the chylomicrons 
and other lipoproteins. It looks as if, following in vitro incubation or in­
travenous administration, the pharmacon binds to the shell to a larger 
extent, due to apposition with the outside of the completed chylomi­
cron. However after oral administration the pharmacon may have 
access to the nucleus to a higher degree. 
In chapter 6 the consequences are described of fatty or non-fatty 
dosage form for the distribution and metabolism of the insecticides 
DDT and aldrin. As already mentioned, an initial passage through the 
liver is avoided when a drug is absorbed selectively via the lymphatics. 
As has been demonstrated in chapter 3, selective absorption via 
lymphatics after oral administration of a compound can be obtained 
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when it is given in a fatty dosage form. On the other hand when a 
non-fatty dosage form is used the absorption from the gut mainly 
occurs via the portal system. From the results presented here it 
appears, that, if DDT is forced (by the non-fatty dosage form) to take 
the absorption route via the liver, then a considerable amount of meta-
bolite is found. However practically no metabolite was found when 
transport via the lymphatics occurs. These findings support the idea 
that differences in the absorption route may have far-reaching con-
sequences for the metabolism and distribution, and in its turn the 
pharmacologic action, of a compound. 
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STELLINGEN 
I 
Het lymfatische systeem van de darm speelt een belangrijke rol bij de 
resorptie van een aantal vetoplosbare geneesmiddelen Dit kan m een 
aantal gevallen belangrijke farmacologische consequenties hebben 
Dit proefschrift 
II 
De langdurige opslag van DDT in het lichaamsvet van mens en dier is 
waarschijnlijk voor een belangrijk deel te wijten aan het onder andere 
met de grote lipofiliteit van dit insecticide samenhangende resorptie- en 
distributiepatroon en minder aan de inertheid van DDT ten aanzien van 
het levermetabohsme 
Hayes W J, in Drills Pharmacology m Médecine (DiPalma J R ed ) ρ 994 
Mc Graw- Hill Book Cp . New York (1965) 
Dit proefschrift 
III 
De door Levine op grond van experimenten met een drietal oraal toe­
gediende quaternaire ammomumverbindingen getrokken conclusie, dat 
"the degree of lipoid solubility may not determine the proportion of 
absorbed material leaving via the lymph", is alleen geldig voor phar-
maca met een relatief lage lipofiliteit 
Levine R R, Marco Τ J de and Dizon C M . ' The lymphatic system its role in the 
absorption and distribution of drugs , in 4th Intern Congr on Pharmacol, Basel 1969, 
vol II (Eigenmann, ed ), Schwabe and Co, Publishers Basel (1969) 
Dit proefschrift 
IV 
De bevindingen van Giannina et al, dat na orale toediening in sesam-
olie, al of met gecombineerd met monooleïde, de ductus thoracicus 
lymfe van de rat slechts ongeveer 0,4 procent van het toegediende 
ethmyloestradiol bevat, maar daarentegen tot ongeveer 16 procent van 
het toegedmede quinestrol, worden verklaard door aan te nemen, dat 
qumestrol gebonden wordt (chemisch of fysisch) aan vetzuren en/of 
monoglycerides. Op grond van de resultaten van dit proefschrift blijkt 
echter dat de mate van lipofiliteit van quinestrol in eerste instantie be-
palend is voor diens opname in chylomicronen en andere lipoproteïnen 
en vervolgens voor het transport via de lymftractus. 
Giannina T., Steinetz В. G. and Meli Α., Intern. J. of Fertility 12, 155-157 (1967). 
Dit proefschrift. 
V 
De isolatie van β - adrenerge receptoren zoals beschreven door 
Lefkowitz roept twijfels op met betrekking tot de identificatie van de 
geïsoleerde, catecholamines bindende fractie als β - adrenerge recep­
toren. 
Lefkowitz R. J., Haber E. and O'Hara D. Proc. Nat. Acad. Sci. 69, 2828-2832 (1972). 
VI 
De bewering dat bij de secretie van maagzuur onder alle omstandig­
heden het histamine als intermediair in het geding zou zijn is aan 
twijfel onderhevig. 
Hirschowitz B. I. and Sachs G. Fed. Proc. 27, 1318-1321 (1969). 
Kasbekar D. K., in: Gastric Secretion (Sachs G. et al., eds.) p. 203, Acad. Press, New 
York (1972). 
VII 
In acht genomen de activiteiten van de apotheker in het kader van de 
geneesmiddelenvoorziening is opname in de farmaceutische studie van 
instructies betreffende administratie en economie gewenst. 
VIII 
De recente gebeurtenissen inzake Vietnam tonen opnieuw aan, dat de 
strikte onpartijdigheid van een hulpverlenende instantie, zoals het Rode 
Kruis, wezenlijk is voor een adequate hulpverlening. 
IX 
Met betrekking tot de risico's voor het milieu en de gevaren verbonden 
aan het gebruik van DDT dient men voor- en nadelen van het gebruik 
van deze stof van geval tot geval goed tegen elkaar af te wegen. Het 
blindelings vervangen ervan door andere stoffen, waarvan een grotere 
veiligheid niet bewezen is, moet worden afgewezen. Het vervangen 
ervan door stoffen die als veiliger beschouwd worden op grond van 
een geringere kennis omtrent hun eigenschappen bergt ernstige ge­
varen in zich. 
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Burnside О. С , Purer J. D. and Roselle R. E., Clinical Toxicol. 4, 63-77 (1971). 
X 
Bij het stellen van voorschriften met betrekking tot de geneesmiddelen­
voorziening dienen de belangen van de patiënt en niet de historische 
rechten van apotheker en arts als uitgangspunt te gelden. Bij een der-
gelijke benadering zal de plaats van de apotheker een duidelijk 
andere worden dan ze in het verleden was. 
XI 
Het toenemend gebruik van slaapmiddelen en tranquilizers, goeddeels 
op doktersvoorschrift, vormt een probleem van tenminste gelijke om-
vang als het probleem van het zogenoemd druggebruik en verdient 
derhalve minstens zo veel aandacht. 
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